This is a Validated Antibody Database (VAD) review about mouse Cd3g, based on 618 published articles (read how Labome selects the articles), using Cd3g antibody in all methods. It is aimed to help Labome visitors find the most suited Cd3g antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cd3g synonym: Ctg-3; Ctg3; T3g

Invitrogen
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:50; loading ...
Invitrogen Cd3g antibody (eBioscience, 11-0032-82) was used in flow cytometry on mouse samples at 1:50. Nat Commun (2022) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; human; 1:100; fig s5a
Invitrogen Cd3g antibody (Invitrogen, 17-0031-81) was used in flow cytometry on human samples at 1:100 (fig s5a). Nat Commun (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; loading ...
Invitrogen Cd3g antibody (Thermo Fisher Scientific, RM-9107-S) was used in immunohistochemistry on mouse samples . Nat Commun (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 5d
Invitrogen Cd3g antibody (Epredia Labvision, RM9107R7) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 5d). Cell Mol Gastroenterol Hepatol (2022) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; loading ...; fig 7c, 7d, 7e
Invitrogen Cd3g antibody (eBioscience, 56-0033-82) was used in flow cytometry on mouse samples (fig 7c, 7d, 7e). PLoS Pathog (2022) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 7c, 7d, 7e
Invitrogen Cd3g antibody (eBioscience, 11-0031-86) was used in flow cytometry on mouse samples (fig 7c, 7d, 7e). PLoS Pathog (2022) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; rat; 1:500; loading ...; fig 5c
Invitrogen Cd3g antibody (Thermo Fisher, MA1-90582) was used in immunohistochemistry - frozen section on rat samples at 1:500 (fig 5c). Sci Rep (2022) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s1l
Invitrogen Cd3g antibody (eBioscience, 11-0031-85) was used in flow cytometry on mouse samples (fig s1l). Cell Rep (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:300; loading ...; fig 1c, s3b
Invitrogen Cd3g antibody (eBioscience, 17-0032-80) was used in flow cytometry on mouse samples at 1:300 (fig 1c, s3b). Development (2022) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 1 ug/ml; loading ...; fig 1d
Invitrogen Cd3g antibody (Thermo Fisher, 16-0031) was used in blocking or activating experiments on mouse samples at 1 ug/ml (fig 1d). J Exp Med (2022) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (ThermoFisher, MA5-17655) was used in flow cytometry on mouse samples . iScience (2022) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:40; fig s4b
Invitrogen Cd3g antibody (Thermo Fisher, 12-0031-82) was used in flow cytometry on mouse samples at 1:40 (fig s4b). J Clin Invest (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen Cd3g antibody (Invitrogen, 11-0032-82) was used in flow cytometry on mouse samples (fig s3). J Neuroinflammation (2022) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 1b
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1b). Front Immunol (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s3, 4a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s3, 4a). Int J Mol Sci (2022) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 5c
Invitrogen Cd3g antibody (eBioscience, 16-0031-85) was used in blocking or activating experiments on mouse samples (fig 5c). J Clin Invest (2022) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig s1g
Invitrogen Cd3g antibody (eBiocience, 16-0031-85) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig s1g). EMBO Mol Med (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; human; loading ...; fig s2b
Invitrogen Cd3g antibody (Thermo Fisher Scientific, 17A2) was used in flow cytometry on human samples (fig s2b). Front Immunol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 56-0032-82) was used in flow cytometry on mouse samples . Theranostics (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s4b
Invitrogen Cd3g antibody (eBioscience, 47-0032-82) was used in flow cytometry on mouse samples (fig s4b). Cell Rep (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:800; loading ...
Invitrogen Cd3g antibody (eBioscience, 12-0031-82) was used in flow cytometry on mouse samples at 1:800. Cells (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 4c
Invitrogen Cd3g antibody (eBioscience, 48-0032-82) was used in flow cytometry on mouse samples at 1:100 (fig 4c). Cells (2021) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 7f
Invitrogen Cd3g antibody (Thermo Invitrogen, 300318) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 7f). Arterioscler Thromb Vasc Biol (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 1a). Aging Dis (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3c
Invitrogen Cd3g antibody (THERMOFISHER, MA5-14,524) was used in immunohistochemistry on mouse samples at 1:500 (fig 3c). Sci Rep (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; fig 6f
Invitrogen Cd3g antibody (Invitrogen, 35-0031-80) was used in flow cytometry on mouse samples at 1:100 (fig 6f). Cell Rep (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 3b
Invitrogen Cd3g antibody (ThermoScientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 3b). J Inflamm Res (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...; fig s5
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples at 1:200 (fig s5). Nat Commun (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s7
Invitrogen Cd3g antibody (eBioscience, 460032-80) was used in flow cytometry on mouse samples (fig s7). Mol Cancer (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Cd3g antibody (eBioscience, 25-0031-81) was used in flow cytometry on mouse samples (fig 2a). Cell Mol Gastroenterol Hepatol (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1d, 3f
Invitrogen Cd3g antibody (eBioscience/Thermo Scientific, 145-2C11) was used in flow cytometry on mouse samples (fig 1d, 3f). Mucosal Immunol (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100; loading ...; fig 1d
Invitrogen Cd3g antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry on human samples at 1:100 (fig 1d). Neuropathol Appl Neurobiol (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2i
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:1000 (fig 2i). Nat Commun (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
Invitrogen Cd3g antibody (eBioscience, 48-0031-82) was used in flow cytometry on mouse samples . Mucosal Immunol (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1a). Acta Naturae (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig s6d
Invitrogen Cd3g antibody (eBioscience, 11-0032-82) was used in flow cytometry on mouse samples at 1:200 (fig s6d). Nat Commun (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen Cd3g antibody (Thermo Fisher, 145-2C11) was used in flow cytometry on mouse samples (fig s3). Cell Death Dis (2021) ncbi
rat monoclonal (17A2)
  • blocking or activating experiments; mouse; loading ...
Invitrogen Cd3g antibody (Invitrogen, 17A2) was used in blocking or activating experiments on mouse samples . Arthritis Res Ther (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...
Invitrogen Cd3g antibody (Invitrogen, 48-0032-82) was used in flow cytometry on mouse samples at 1:200. Front Immunol (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s4a
Invitrogen Cd3g antibody (eBioscience, 17-0031-83) was used in flow cytometry on mouse samples (fig s4a). Blood (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Front Immunol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5e
Invitrogen Cd3g antibody (ThermoFisher, 17-0032-82) was used in flow cytometry on mouse samples at 1:100 (fig 5e). FASEB J (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2a, 2b, s10
Invitrogen Cd3g antibody (eBioscience, 45-0031-82) was used in flow cytometry on mouse samples (fig 2a, 2b, s10). Nat Commun (2021) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s6e
Invitrogen Cd3g antibody (Invitrogen, 14-0032-82) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6e). Sci Adv (2021) ncbi
hamsters monoclonal (145-2C11)
  • western blot; mouse; 1:1000; loading ...; fig 3f
Invitrogen Cd3g antibody (Thermofisher, 145-2C11) was used in western blot on mouse samples at 1:1000 (fig 3f). Protein Cell (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s8
Invitrogen Cd3g antibody (eBioscience, 17-0032-82) was used in flow cytometry on mouse samples (fig s8). Commun Biol (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...; fig s1
Invitrogen Cd3g antibody (eBiosciences, 17-0031-82) was used in flow cytometry on mouse samples at 1:200 (fig s1). Nat Immunol (2021) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig s1c
  • flow cytometry; mouse; 1:100; loading ...; fig 1a, 2
Invitrogen Cd3g antibody (eBioscience, 14003182) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig s1c) and in flow cytometry on mouse samples at 1:100 (fig 1a, 2). J Neuroinflammation (2021) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:600; loading ...; fig e1j
Invitrogen Cd3g antibody (Thermo Fischer, RM-9107-S1) was used in immunohistochemistry - paraffin section on mouse samples at 1:600 (fig e1j). EMBO Rep (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:200 (fig 4b). EMBO Rep (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...
Invitrogen Cd3g antibody (Invitrogen, 48-0032-82) was used in flow cytometry on mouse samples . J Clin Invest (2021) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; loading ...; fig 2g
Invitrogen Cd3g antibody (eBioscience, 14-0032-81) was used in immunohistochemistry on mouse samples (fig 2g). Theranostics (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (Invitrogen, 145-2C11) was used in flow cytometry on mouse samples . Aging Cell (2021) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen Cd3g antibody (eBioscience, 145-2 C11) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...
Invitrogen Cd3g antibody (Invitrogen, 145-2C11) was used in flow cytometry on mouse samples at 1:200. Hepatol Commun (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
Invitrogen Cd3g antibody (Thermo Fisher, 145-2C11) was used in flow cytometry on mouse samples . Front Immunol (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen Cd3g antibody (eBioscience, 145?C2 C11) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Aging Cell (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen Cd3g antibody (Thermo Fisher Scientific, 145-C2 C11) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s2a
  • immunohistochemistry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s2a) and in immunohistochemistry on mouse samples . Cell (2020) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4g
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry - frozen section on mouse samples (fig 4g). Sci Immunol (2020) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry; mouse; fig 4a
Invitrogen Cd3g antibody (eBioscience, 16-0031) was used in immunohistochemistry on mouse samples (fig 4a). Basic Res Cardiol (2020) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 2d
Invitrogen Cd3g antibody (Thermo Fisher, 500A2) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 2d). elife (2020) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 4i
Invitrogen Cd3g antibody (ThermoFisher, 14-0031-82) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 4i). Nat Commun (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; human; 1:100; loading ...; fig 6a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on human samples at 1:100 (fig 6a). Front Immunol (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:300; loading ...; fig s7b
Invitrogen Cd3g antibody (Invitrogen, 11-0032-82) was used in flow cytometry on mouse samples at 1:300 (fig s7b). Cell Res (2020) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6e
Invitrogen Cd3g antibody (eBioscience, 14-0032) was used in immunohistochemistry on mouse samples at 1:100 (fig 6e). Proc Natl Acad Sci U S A (2020) ncbi
Syrian golden hamster monoclonal (500A2)
  • flow cytometry; mouse; 1 ug/ml; loading ...; fig s3a, s20a, s20c
Invitrogen Cd3g antibody (eBioscience, 500A2) was used in flow cytometry on mouse samples at 1 ug/ml (fig s3a, s20a, s20c). Science (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s1
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s1). elife (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen Cd3g antibody (Thermo Fisher, 145-2C11) was used in flow cytometry on mouse samples (fig 3c). Sci Adv (2020) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5a
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry - paraffin section on mouse samples (fig 5a). Acta Neuropathol (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 5a
Invitrogen Cd3g antibody (eBioscience, 17-0032-82) was used in flow cytometry on mouse samples (fig 5a). Aging (Albany NY) (2020) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:800; loading ...; fig s3a
Invitrogen Cd3g antibody (eBioscience, 14?C0032-81) was used in immunohistochemistry on mouse samples at 1:800 (fig s3a). Nature (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:800; fig s15b
Invitrogen Cd3g antibody (Thermo Fisher, 48-0031-80) was used in flow cytometry on mouse samples at 1:800 (fig s15b). Nat Commun (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s3a, s3b, s7c
Invitrogen Cd3g antibody (ThermoFisher, 48-0032-82) was used in flow cytometry on mouse samples (fig s3a, s3b, s7c). Cell Rep (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig 6
Invitrogen Cd3g antibody (eBioscience, 17-0032) was used in flow cytometry on mouse samples at 1:200 (fig 6). JCI Insight (2020) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig e9g
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig e9g). Nature (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:50; loading ...; fig e1a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:50 (fig e1a). Nature (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples . Front Immunol (2019) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3h
Invitrogen Cd3g antibody (Ebioscience, 14?C0032-81) was used in immunohistochemistry on mouse samples at 1:200 (fig 3h). Cell Stem Cell (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2k
Invitrogen Cd3g antibody (eBioscience, 56-0032-82) was used in flow cytometry on mouse samples (fig s2k). Sci Adv (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:40; loading ...; fig s3a
Invitrogen Cd3g antibody (eBioscience, 17-0032-82) was used in flow cytometry on mouse samples at 1:40 (fig s3a). Nat Commun (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; fig s7d
Invitrogen Cd3g antibody (Invitrogen, 35-0031-80) was used in flow cytometry on mouse samples at 1:100 (fig s7d). Cancer Cell (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; fig s7d
Invitrogen Cd3g antibody (eBioscience, 50-0032-82) was used in flow cytometry on mouse samples at 1:100 (fig s7d). Cancer Cell (2019) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 2e
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 2e). Sci Adv (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3b
Invitrogen Cd3g antibody (Themo, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3b). elife (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 3g, e7h
Invitrogen Cd3g antibody (eBioscience, 48-0031-82) was used in flow cytometry on mouse samples (fig 3g, e7h). Nature (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:1000; loading ...; fig e2j, e8a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:1000 (fig e2j, e8a). Nature (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig e2n
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples at 1:200 (fig e2n). Nature (2019) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig s4a
Invitrogen Cd3g antibody (Thermofisher, MA1-90582) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig s4a). Cancer Cell (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...; fig s1e
Invitrogen Cd3g antibody (eBioscience, 11-0031-82) was used in flow cytometry on mouse samples at 1:200 (fig s1e). Nat Commun (2019) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 1a
Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 1a). J Exp Med (2019) ncbi
Syrian golden hamster monoclonal (500A2)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Cd3g antibody (Thermo Fisher Scientific, HM3428) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Cd3g antibody (Thermo Fisher Scientific, 12-0031-83) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:1000; loading ...; fig 5a
Invitrogen Cd3g antibody (eBioscience, 11-0031) was used in flow cytometry on mouse samples at 1:1000 (fig 5a). Cell (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig s3d
Invitrogen Cd3g antibody (eBioscience, 48-0032-82) was used in flow cytometry on mouse samples at 1:100 (fig s3d). Cell (2019) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 4a). Immune Netw (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen Cd3g antibody (eBioscience, 17-0031-83) was used in flow cytometry on mouse samples (fig 6a). Cell (2019) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 1a
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry on mouse samples at 1:400 (fig 1a). Neuroscience (2019) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1e
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Cd3g antibody (eBioscience, 2C11) was used in immunohistochemistry - frozen section on mouse samples (fig 1e) and in flow cytometry on mouse samples (fig s1a). Nat Commun (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s3b
Invitrogen Cd3g antibody (eBiosciences, 145-2 C11) was used in flow cytometry on mouse samples (fig s3b). Ann Rheum Dis (2019) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4a
Invitrogen Cd3g antibody (eBiosciences, ebio500A2) was used in immunohistochemistry - paraffin section on mouse samples (fig 4a). Ann Rheum Dis (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s3a
Invitrogen Cd3g antibody (Thermo Fisher, 17A2) was used in flow cytometry on mouse samples (fig s3a). J Clin Invest (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig s3f
Invitrogen Cd3g antibody (eBioscience, 56-0032-80) was used in flow cytometry on mouse samples at 1:100 (fig s3f). Nat Commun (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 1b). PLoS Pathog (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen Cd3g antibody (eBioscience, 47-0032-82) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; loading ...; fig s3b
Invitrogen Cd3g antibody (eBioscience, 45-0031-82) was used in flow cytometry on mouse samples at 1:100 (fig s3b). Nat Commun (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen Cd3g antibody (eBioscience, 145?\2C11) was used in flow cytometry on mouse samples (fig 6b). EMBO J (2019) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6c
  • flow cytometry; mouse; loading ...; fig 6b
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c) and in flow cytometry on mouse samples (fig 6b). Front Microbiol (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 6d
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 6d). Obesity (Silver Spring) (2018) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; 1:30; loading ...; fig s7c
Invitrogen Cd3g antibody (eBioscience, 50-0032) was used in immunohistochemistry - frozen section on mouse samples at 1:30 (fig s7c). Cell Res (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2018) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig s5b
Invitrogen Cd3g antibody (Thermo Fisher Scientific, 16-0031-82) was used in blocking or activating experiments on mouse samples (fig s5b). Immunity (2018) ncbi
rat monoclonal (17A2)
  • blocking or activating experiments; mouse; loading ...; fig s3b
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in blocking or activating experiments on mouse samples (fig s3b). Eur J Immunol (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:250; loading ...; fig s11a
Invitrogen Cd3g antibody (Thermo Fisher Scientific, 47-0031-82) was used in flow cytometry on mouse samples at 1:250 (fig s11a). Nat Commun (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:20; loading ...; fig 2m
Invitrogen Cd3g antibody (Thermo Fisher, SP7) was used in immunohistochemistry on mouse samples at 1:20 (fig 2m). J Exp Med (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 1c). Front Immunol (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen Cd3g antibody (ThermoFisher, 145-2C11) was used in flow cytometry on mouse samples (fig s2a). PLoS Pathog (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3b
Invitrogen Cd3g antibody (Thermo Fisher Scientific, Sp7) was used in immunohistochemistry - paraffin section on human samples (fig 3b). J Clin Invest (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 1c). Cell Stem Cell (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:150; loading ...; fig s3a
Invitrogen Cd3g antibody (eBioscience, 17-0032-80) was used in flow cytometry on mouse samples at 1:150 (fig s3a). Nat Commun (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s2). Cancer Res (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; human; loading ...; fig 5e
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on human samples (fig 5e). Mol Ther Methods Clin Dev (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s5d
Invitrogen Cd3g antibody (ebioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s5d). Science (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1). Front Immunol (2018) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 1b
Invitrogen Cd3g antibody (Thermo Fisher, 17A2) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 1b). J Clin Invest (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5a
Invitrogen Cd3g antibody (eBiosciences, 17A2) was used in flow cytometry on mouse samples at 1:100 (fig 5a). Nat Commun (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s2b). Cell Metab (2018) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • immunohistochemistry; mouse; loading ...; fig s1b
Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in immunohistochemistry on mouse samples (fig s1b). Science (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s4a
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig s4a). PLoS ONE (2018) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 1b
Invitrogen Cd3g antibody (Thermo Fisher Scientific, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 1b). J Immunol (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s1a). J Exp Med (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s11c
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s11c). Science (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 4f
Invitrogen Cd3g antibody (eBiosciences, 17A2) was used in flow cytometry on mouse samples (fig 4f). J Clin Invest (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; loading ...; fig 1c
Invitrogen Cd3g antibody (eBioscience, 12-0031-82) was used in flow cytometry on mouse samples at 1:100 (fig 1c). Development (2018) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1g
Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in immunohistochemistry - frozen section on mouse samples (fig 1g). Proc Natl Acad Sci U S A (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s4c
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s4c). Nature (2018) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; fig s2d
Invitrogen Cd3g antibody (eBiosciences, 11-0033-82) was used in flow cytometry on mouse samples (fig s2d). Cell (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 3b). Nature (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2d). Nat Commun (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 6a
Invitrogen Cd3g antibody (eBiosciences, 11-0031-85) was used in flow cytometry on mouse samples (fig 6a). Cell (2018) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2b
Invitrogen Cd3g antibody (ThermoFisher, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 2b). Cell (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 7a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 7a). Cell (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:400; loading ...
Invitrogen Cd3g antibody (ebioscience, 17A2) was used in flow cytometry on mouse samples at 1:400. Nat Commun (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 3a
In order to investigate the important of Ly49A ITIM signaling in NK-cell effector inhibition, licensing, and receptor repertoire development, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2017) ncbi
hamsters monoclonal (145-2C11)
  • immunocytochemistry; mouse; 1:50; loading ...; fig 1g
Invitrogen Cd3g antibody (eBioscience, 2C11) was used in immunocytochemistry on mouse samples at 1:50 (fig 1g). Nat Commun (2017) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry; mouse; loading ...; fig s3b
Invitrogen Cd3g antibody (eBioscience, 145-2c11) was used in immunohistochemistry on mouse samples (fig s3b). FASEB J (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 3c
In order to study the involvement of the Ox40/Ox40 ligand pathway in systemic lupus erythematosus, Invitrogen Cd3g antibody (eBioscience, 56-032) was used in flow cytometry on mouse samples (fig 3c). J Immunol (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 3d
In order to investigate the involvement of Sec22b in antigen cross-presentation and antitumor immunity, Invitrogen Cd3g antibody (eBiosciences, 48-0032-80) was used in flow cytometry on mouse samples (fig 3d). J Exp Med (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig s6g
In order to study the role of reprogrammed BCAA metabolism in the progression of myeloid leukaemia, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig s6g). Nature (2017) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; loading ...; tbl s1
In order to elucidate the effect of S100 calcium-binding proteins A8/A9 on thrombocytosis and atherogenesis in diabetes, Invitrogen Cd3g antibody (eBioscience, 11-0033-82) was used in flow cytometry on mouse samples (tbl s1). J Clin Invest (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen Cd3g antibody (eBiosciences, 45-0031-80) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2017) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig s15g
In order to study the effects of interleukin-10 on macrophages and inflammation, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in blocking or activating experiments on mouse samples (fig s15g). Science (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s1.4b
In order to investigate the generation of macrophage populations during homeostasis and inflammation, Invitrogen Cd3g antibody (eBiosciences, 17A2) was used in flow cytometry on mouse samples (fig s1.4b). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; fig 1b
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, Invitrogen Cd3g antibody (ebioscience, eBio500A2) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1 ug/ml; loading ...; fig 4b
In order to elucidate how schistosome-induced B cells protect against allergic airway inflammation, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples at 1 ug/ml (fig 4b). Int J Parasitol (2017) ncbi
hamsters monoclonal (145-2C11)
  • other; mouse; fig s2a
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in other on mouse samples (fig s2a). J Clin Invest (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig s2c
In order to demonstrate that type 1 T helper cells play a crucial role in vessel normalization, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s2c). Nature (2017) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig s2d
In order to investigate how aging affects transcriptional dynamics in naive and CD4 positive T cells, Invitrogen Cd3g antibody (eBiosciences, 16-0031-82) was used in blocking or activating experiments on mouse samples (fig s2d). Science (2017) ncbi
rat monoclonal (17A2)
  • blocking or activating experiments; mouse; loading ...; fig 6e
In order to clarify the mechanisms by which miR-21 contributes to oncogenesis, Invitrogen Cd3g antibody (eBioscience, 16-0032-85) was used in blocking or activating experiments on mouse samples (fig 6e). Oncogene (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s8i
In order to explore the lung as a site of platelet biogenesis, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s8i). Nature (2017) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 9
In order to study acute kidney injury in mice by noninvasive measurement of renal perfusion and tissue edema using functional MRI, Invitrogen Cd3g antibody (eBioscience, 2C11) was used in immunohistochemistry on mouse samples at 1:200 (fig 9). PLoS ONE (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:400; loading ...; fig s1c
In order to report a CD40-dependent mechanism capable of abrogating inducible T regulatory cell induction by dendritic cells, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:400 (fig s1c). Nat Commun (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 4a
In order to infer a RANKL-dependent osteoclastogenesis after debridement of osteomyelitis coinciding with elevated B cells and simultaneously decreased osteogenesis, Invitrogen Cd3g antibody (eBiosciences, 11-0031-85) was used in flow cytometry on mouse samples (fig 4a). J Orthop Res (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1c,d
In order to examine the contribution of stroma-derived osteopontin for hematopoietic stem cell aging, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1c,d). EMBO J (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2a
In order to examine the localization and function of FHL2 in natural killer cells, Invitrogen Cd3g antibody (Affymetrix eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2a). Front Immunol (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s2g
In order to demonstrate that loss of autophagy results in the accumulation of mitochondria and an activated metabolic state of hematopoietic stem cells, Invitrogen Cd3g antibody (eBiosciences, 17-0032-82) was used in flow cytometry on mouse samples (fig s2g). Nature (2017) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 3
In order to study the D. farinae allergen Pplase in a mouse model., Invitrogen Cd3g antibody (Ebioscience, 16-0031-82) was used in blocking or activating experiments on mouse samples (fig 3). Sci Rep (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 4a
In order to explore the role of Nol3 in myeloproliferative neoplasms, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 4a). J Exp Med (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig S6
In order to study a mouse model of anti-human PD-L1 for developing new cancer treatments., Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig S6). Sci Rep (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...; fig 5a
In order to evaluate the use of a recombinant Newcastle disease virus expressing ICOS ligand to treat cancer, Invitrogen Cd3g antibody (eBioscience, 25-0031) was used in flow cytometry on mouse samples at 1:200 (fig 5a). Nat Commun (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 7
In order to find that Th40 cells drive a rapid, more severe experimental autoimmune encephalomyelitis disease course than conventional CD4 T cells, Invitrogen Cd3g antibody (eBioscience, 145.2C11) was used in flow cytometry on mouse samples (fig 7). PLoS ONE (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1d
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen Cd3g antibody (eBioscience, 11-0031) was used in flow cytometry on mouse samples (fig 1d). Sci Rep (2017) ncbi
rat monoclonal (CD3-12)
  • immunohistochemistry - frozen section; rhesus macaque; loading ...; fig 2a
In order to study CXCR5+ CD8 T cells in SIV-infected animals, Invitrogen Cd3g antibody (Thermo Fischer, CD3-12) was used in immunohistochemistry - frozen section on rhesus macaque samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 4a
In order to assess the use of anti-CCR4 antibody in a mouse model of renal cell carcinoma, Invitrogen Cd3g antibody (eBioscience, 45-0031) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 6c
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 6c). Cell Mol Life Sci (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s3
In order to examine the role of herpes virus entry mediator in corneal disease during viral infection, Invitrogen Cd3g antibody (eBiosciences, 17A2) was used in flow cytometry on mouse samples (fig s3). Invest Ophthalmol Vis Sci (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s2
In order to examine the role of herpes virus entry mediator in corneal disease during viral infection, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig s2). Invest Ophthalmol Vis Sci (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2c
In order to test if MSI2 modulates FLT3 expression, Invitrogen Cd3g antibody (ebioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2c). Leuk Res (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1g
In order to assess the effects of dietary fiber and short chain fatty acids on the intestinal immune system and microbiota, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1g). J Immunol (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:80; fig 1e
In order to determine a physiological role for IL-1beta and insulin in the regulation of both metabolism and immunity, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:80 (fig 1e). Nat Immunol (2017) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 2f
In order to analyze the in vivo effect of atorvastatin on regulatory T cells and its association with the inflammatory process in a model of allergic asthma, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 2f). Front Immunol (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 1 ug/ml; loading ...
In order to assess if aerobic glycolysis and glutaminolysis co-operatively reduce UDP-GlcNAc biosynthesis and N-glycan branching in mouse T cell blasts, Invitrogen Cd3g antibody (eBioscience, 145-2 C11) was used in blocking or activating experiments on mouse samples at 1 ug/ml. elife (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2l
In order to establish a method to isolate apoptotic bodies from cultured cells to 99% purity, Invitrogen Cd3g antibody (eBioscience, 17-0031-83) was used in flow cytometry on mouse samples (fig 2l). Sci Rep (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...; fig 4a
In order to study the role of oxidative stress in optic neuritis, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:200 (fig 4a). Mol Vis (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1
In order to examine natural killer T cell development in mice deficient for SLAM family receptors, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 7G
In order to analyze the effects of a loss of autophagy in dendritic cells and B cells in a TLR7-mediated model of autoimmunity, Invitrogen Cd3g antibody (eBioscience, 48-0032-80) was used in flow cytometry on mouse samples (fig 7G). J Immunol (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1h
In order to explore the role of PKCalpha-DOCK8-Cdc42 signaling in T cell migration, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1h). J Exp Med (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 5
In order to employ ChIP-seq to analyze PAX8-PPARG fusion protein binding sites in a PAX8-PPARG fusion protein follicular thyroid carcinoma mouse model, Invitrogen Cd3g antibody (Thermo Fischer Scientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 5). Oncotarget (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
In order to explore if the anti-diabetic sulphonylurea glibenclamide protects insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . PLoS ONE (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2a
In order to report the molecular changes involve in stem cell differentiation, Invitrogen Cd3g antibody (eBioscience, 17-0032-80) was used in flow cytometry on mouse samples (fig s2a). Nucleic Acids Res (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s2
In order to report the molecular changes involve in stem cell differentiation, Invitrogen Cd3g antibody (eBioscience, 13-0031-75) was used in flow cytometry on mouse samples (fig s2). Nucleic Acids Res (2017) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:300; loading ...; fig 4a
In order to examine the contribution of type 2 innate lymphocytes to spinal cord injury, Invitrogen Cd3g antibody (eBioscience, 50-0032) was used in immunohistochemistry on mouse samples at 1:300 (fig 4a). J Exp Med (2017) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 2b
In order to elucidate the mechanisms by which conserved non-coding sequence 2 demethylation in maintained, Invitrogen Cd3g antibody (eBiosciences, 2C11) was used in blocking or activating experiments on mouse samples (fig 2b). Mol Cells (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig s3e
In order to discuss how NLRC3 protects against colorectal cancer by modulating mTor signaling, Invitrogen Cd3g antibody (Affymetrix eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig s3e). Nature (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 3
In order to study the role of T cells in the effector phase of antibody-mediated autoimmune dermatoses, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 5j
In order to determine the role of IL-17A in airway fibrosis, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 5j). Am J Physiol Lung Cell Mol Physiol (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5a
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 5a). Cell (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; loading ...; fig s1b
In order to use transgenic mice to assess the effects of progressively disrupting Hras and Nras genes on urethane lung tumorigenesis, Invitrogen Cd3g antibody (ThermoFisher, RM9107) was used in immunohistochemistry on mouse samples (fig s1b). PLoS ONE (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
In order to use knockout mice to determine if GRK6 contributes to hematopoiesis, Invitrogen Cd3g antibody (eBioscience, 145-2c11) was used in flow cytometry on mouse samples . Cell Death Dis (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5a
In order to elucidate the mechanism by which CYP26A1 contributes to the maintenance of pregnancy, Invitrogen Cd3g antibody (eBioscience, 12-0031) was used in flow cytometry on mouse samples (fig 5a). J Cell Mol Med (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 4f
In order to explore how apoptotic intestinal epithelial cells are processed and sampled, Invitrogen Cd3g antibody (eBioscience, 145-2c11) was used in flow cytometry on mouse samples (fig 4f). Nature (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...; fig 4c
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:200 (fig 4c). Nat Commun (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2a
In order to identify a role for HIV p17 in the development of leukemia/lymphoma, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2a). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s4b
In order to elucidate the contribution of Ptpn11 mutations in the bone marrow microenvironment to leukaemogenesis, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s4b). Nature (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
In order to look for C3d+ microglial clusters in patients with multiple sclerosis, Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Glia (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:400; loading ...; fig 2a
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:400 (fig 2a). J Clin Invest (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 9a
  • flow cytometry; mouse; loading ...; fig s2c
In order to identify and characterize a Nei endonuclease VIII-like 3 mutation in three siblings from a consanguineous family with autoimmunity, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 9a) and in flow cytometry on mouse samples (fig s2c). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; human; 1:150; loading ...; fig 2b
In order to use MALDI-TOF-MS imaging to study immune cells in colon cancer samples, Invitrogen Cd3g antibody (Thermo-Fisher, SP7) was used in immunohistochemistry - frozen section on human samples at 1:150 (fig 2b). J Proteome Res (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples . Mucosal Immunol (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; loading ...; fig 1a
In order to find genes that alter invariant natural killer T cell development, migration, or function, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples at 1:100 (fig 1a). Nat Commun (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s3
Invitrogen Cd3g antibody (eBioscience, 56-0032-82) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
In order to study the effect of IL-13 and IL-33 pathways in dysregulated type 2 inflammation., Invitrogen Cd3g antibody (eBioscience, 2C11) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse; 1:100; loading ...
In order to characterize Tnip1-deficient mice as a model for psoriasis, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples at 1:100. Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; fig 3
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 3). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
In order to clarify the B cell-intrinsic functions of c-REL and RELA, Invitrogen Cd3g antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). Immunol Cell Biol (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s7h
In order to investigate how PI3Kgamma regulates macrophage polarization, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig s7h). Nature (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1a
In order to study immune cells infiltration and renal injury in CCL5 KO mice., Invitrogen Cd3g antibody (Laboratory Vision, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig s1a). Am J Pathol (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 1e
In order to investigate the effects of modulating potassium ion concentration on T cell effector functions, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 1e). Nature (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to analyze small-cell lung cancer samples for CD274 mutations, Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Clin Cancer Res (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig S3
In order to study the effect of IL-10 signaling in infectious neurological diseases, Invitrogen Cd3g antibody (eBioscience, clone 145-2C11) was used in flow cytometry on mouse samples (fig S3). PLoS ONE (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2h
In order to elucidate the role of Tbet in acute lung injury, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2h). J Leukoc Biol (2017) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; 1:200; tbl 1
Invitrogen Cd3g antibody (eBiosciences, eBio500A2) was used in flow cytometry on mouse samples at 1:200 (tbl 1). Nat Commun (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (Ebioscience, 11-0031) was used in flow cytometry on mouse samples . BMC Complement Altern Med (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1b
In order to determine the function of the SLAM family of proteins in natural killer cells, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:80; loading ...; fig 10a
In order to use poly(ethylene glycol)-functionalized-hydrophilic carbon clusters to track T cells in vivo, Invitrogen Cd3g antibody (Ebioscience, 17-0032) was used in flow cytometry on mouse samples at 1:80 (fig 10a). NMR Biomed (2016) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; loading ...; fig 1b
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen Cd3g antibody (eBioscience, 500A2) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1c
In order to study changes in IL-23 and IL-22 after scratching, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig 2b
In order to study changes in IL-23 and IL-22 after scratching, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 2b). J Exp Med (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 7
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 7). Nat Commun (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to find a role for Car enzymes in regulating mast cell lineage commitment, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Exp Med (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 3c
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 3c). J Clin Invest (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 3c
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 3c). J Clin Invest (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig s1a
In order to examine the role of BRPF1 during hematopoiesis, Invitrogen Cd3g antibody (eBiosciences, 45-0031-80) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 4o
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 4o). Am J Pathol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1a
In order to determine the role of Id3 in germinal center B cells, Invitrogen Cd3g antibody (BD Pharmingen or eBioscience, 2C11) was used in flow cytometry on mouse samples (fig 1a). Mol Cell Biol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig s6a
In order to find a role for RelA in regulating oncogene-induced senescence, Invitrogen Cd3g antibody (ebioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s6a). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to determine the density and distribution of tumor-infiltrating lymphocytes and tertiary lymphoid structures in pulmonary metastases from primary colorectal cancer and correlate them with clinicopathological variables, Invitrogen Cd3g antibody (Thermo Fisher, RM9107-S1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Clin Exp Metastasis (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 8 ug/ml; loading ...; fig s5c
In order to test if modulation of Rho-associated kinase 2 alters the generation of T follicular helper cells, Invitrogen Cd3g antibody (eBioscience, 16-0031-85) was used in blocking or activating experiments on mouse samples at 8 ug/ml (fig s5c). Sci Signal (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 1a). Immunity (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; fig 3h
Invitrogen Cd3g antibody (eBiosience, 16-0031-86) was used in blocking or activating experiments on mouse samples (fig 3h). Nat Commun (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig ex1b
In order to perform live imaging for continuous single-cell long-term quantification of the transcription factors GATA1 and PU.1 and study how these factors influence early myeloid lineage choice, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig ex1b). Nature (2016) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; loading ...; fig 1g
In order to explain how glial cells impact ILC3-derived IL-22, Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in flow cytometry on mouse samples (fig 1g). Nature (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to study the reversal of renal injury and high blood pressure by renal rescue of dopamine D2 receptor function, Invitrogen Cd3g antibody (Thermo Scientific, MA5-14524) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). JCI Insight (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 1 ug/ml
Invitrogen Cd3g antibody (eBioscience, 16-0031) was used in blocking or activating experiments on mouse samples at 1 ug/ml. Nat Commun (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to analyze inhibition of IL-17-mediated colon inflammation and tumorigenesis by ROR-gamma-t ubiquitination by Itch, Invitrogen Cd3g antibody (eBioscience, 25-0031-82) was used in flow cytometry on mouse samples . Nat Immunol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 5). Immunity (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
In order to discuss Staphylococcus aureus-derived allergens, Invitrogen Cd3g antibody (eBioscience, 12-0031-81) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; loading ...; fig 1h
In order to test if senescent stromal cells contribute to tumorigenesis, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:200 (fig 1h). Nat Commun (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s1c
In order to report that human CD11c positive cells are the main VEGF-A-producing cell population in reactive secondary lymphoid organs, Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1c). Oncotarget (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 2 ug/ml; loading ...; fig 1
In order to find that transplanted mesenchymal stromal/stem cells did not attenuate experimental autoimmune encephalomyelitis, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 1). Stem Cells Dev (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
In order to detail how to obtain innate lymphoid cells from isolated common lymphoid progenitors, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples . Bio Protoc (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 3f). PLoS ONE (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 3b
In order to find that coagulation factor XII modulates immune responses, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 3b). Nat Commun (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig s4
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s4). Sci Rep (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:66; loading ...; fig 2f
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen Cd3g antibody (eBioscience, 45-0031-82) was used in flow cytometry on mouse samples at 1:66 (fig 2f). Nat Cell Biol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; fig s3
In order to characterize dysregulation of neuronal network activity following a stroke due to microglia protecting against brain injury and their selective elimination, Invitrogen Cd3g antibody (eBioscience, 17-0031-80) was used in flow cytometry on mouse samples at 1:200 (fig s3). Nat Commun (2016) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:100; fig 1
In order to study regulation of muscle development and PDGRFbeta(+)cell stemness by laminin, Invitrogen Cd3g antibody (eBioscience, 14-0032) was used in immunohistochemistry on mouse samples at 1:100 (fig 1). Nat Commun (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to investigate the effects of IL-1 on hematopoietic stem cells, Invitrogen Cd3g antibody (eBioscience, 17-0032-82) was used in flow cytometry on mouse samples . Nat Cell Biol (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 5 ug/ml; fig 2
Invitrogen Cd3g antibody (eBioscience, 2C11) was used in blocking or activating experiments on mouse samples at 5 ug/ml (fig 2). Nat Immunol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 2d). Sci Rep (2016) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry; mouse; loading ...; fig 4b
In order to study the expression and functional role of stabilin-1 in breast cancer, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in immunohistochemistry on mouse samples (fig 4b). Oncotarget (2016) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; human; 1:100; fig s3
  • flow cytometry; mouse; 1:100; fig s4
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry on human samples at 1:100 (fig s3) and in flow cytometry on mouse samples at 1:100 (fig s4). Nat Commun (2016) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3a
In order to discover that T follicular helper cells preferentially express the transcriptional coactivator Bob1, Invitrogen Cd3g antibody (Life Technologies, 500A2) was used in immunohistochemistry - frozen section on mouse samples (fig 3a). Eur J Immunol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; fig s5
In order to discuss targeting FAK and VEGF for ovarian cancer management, Invitrogen Cd3g antibody (ebioscience, 45-0031-82) was used in flow cytometry on mouse samples at 1:200 (fig s5). J Clin Invest (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 3b
In order to compare methods of generating tumor lysates/cells used for pulsing dendritic cell vaccines, Invitrogen Cd3g antibody (eBioscience, 11-0031-82) was used in flow cytometry on mouse samples (fig 3b). Oncoimmunology (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig s2c
In order to elucidate the relationship between Wnt/beta-catenin and Hippo/YAP signaling during intestinal regeneration and tumorigenesis, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in blocking or activating experiments on mouse samples (fig s2c). Dev Cell (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2c
In order to investigate the role of IL-1beta produced by a T helper 17 cell-intrinsic ASC-NLRP3-caspase-8 inflammasome in experimental autoimmune encephalomyelitis, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:1000 (fig 2c). Nat Immunol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2b
In order to assess the impact of phospholipase C gamma 2 mutations to the development of gastric mucosa-associated lymphoid tissue lymphomas, Invitrogen Cd3g antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2b). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (SP7)
  • flow cytometry; mouse; 1:150; loading ...; fig 4
In order to test whether heat-killed Staphyloccocus aureus inhibits the development of atherosclerosis, Invitrogen Cd3g antibody (Thermo Fischer Scientific, SP7) was used in flow cytometry on mouse samples at 1:150 (fig 4). J Intern Med (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to study how a novel multi-drug metronomic chemotherapy can delay tumor growth in mice significantly, Invitrogen Cd3g antibody (eBioscience, 17-A2) was used in flow cytometry on mouse samples . J Transl Med (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; fig 4
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 4). elife (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; fig 4
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 4). J Exp Med (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 5
In order to determine the role of fibroblast growth factor 21 (FGF21) in protecting from iselt hyperplasia and high fat diet induced inflammation in the pancreas, Invitrogen Cd3g antibody (Thermo Scientific, MA1-90582) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). PLoS ONE (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:200; fig 4
In order to study murine experimental autoimmune encephalomyelitisto find a method for the histopathological study of the multifocal nature of spinal cord lesions, Invitrogen Cd3g antibody (Neomarkers, RM-9107-5) was used in immunohistochemistry on mouse samples at 1:200 (fig 4). Peerj (2016) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5e
In order to suggest that Cmv5 contributes to host resistance against murine cytomegalovirus, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in immunohistochemistry - frozen section on mouse samples (fig 5e). PLoS Pathog (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4b
In order to discuss models of squamous lung tumors to test therapeutic regimens, Invitrogen Cd3g antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4b). J Thorac Oncol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig s1
Invitrogen Cd3g antibody (eBioscience, 12-0031-82) was used in flow cytometry on mouse samples (fig s1). Sci Rep (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 1
Invitrogen Cd3g antibody (eBioscience, 14-0032-85) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 1e
In order to report that the majority of microbe-specific naive T cells produced memory cells during infection, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 1e). Science (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 1
In order to study epithelial control of gut-associated lymphoid tissue formation via p38alpha-dependent restraint of NF-kappaB signaling, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1). J Immunol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 11-0031-85) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 3
Invitrogen Cd3g antibody (eBioscience, 46-0032-82) was used in flow cytometry on mouse samples (fig 3). Front Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 1c
In order to use a murine model of acute oropharyngeal candidiasis to study the contribution of IL-17, Invitrogen Cd3g antibody (Fisher Scientific, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 1c). J Leukoc Biol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • western blot; rat; 1:100; fig 13
In order to investigate the molecular mechanisms that regulate cardiomyocyte necroptosis, Invitrogen Cd3g antibody (Thermo Scientific, RM9107) was used in western blot on rat samples at 1:100 (fig 13). Nat Med (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 6
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 6). PLoS Biol (2015) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; fig 1
In order to determine the role of the toll-like receptor 4-mediated lymphocyte influx as an inducer of neonatal necrotizing enterocolitis, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry on mouse samples (fig 1). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to study nontuberculous mycobacterial infection with mutual IgG4-related lymphadenopathy, Invitrogen Cd3g antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). APMIS (2016) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; loading ...; fig 1d
In order to study the polysialylation of CCR7, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry on mouse samples (fig 1d). Science (2016) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 4a
In order to elucidate the role of TfR1 in adaptive immunity, Invitrogen Cd3g antibody (eBioscience, 145-2C1) was used in blocking or activating experiments on mouse samples (fig 4a). Nat Genet (2016) ncbi
rat monoclonal (17A2)
  • blocking or activating experiments; mouse; loading ...; fig 4a
In order to study the interactions between hepatoma cells and anti-hepatocellular carcinoma T-cells, Invitrogen Cd3g antibody (eBiosciences, 17A2) was used in blocking or activating experiments on mouse samples (fig 4a). Immunol Cell Biol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1
In order to compare multiple sclerosis to autoimmune encephalitis in humans, Invitrogen Cd3g antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Acta Neuropathol Commun (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to study genetic lineage tracing to identify cardiomyocytes and in situ Kit-expression, Invitrogen Cd3g antibody (eBioscience, 25-0031) was used in flow cytometry on mouse samples . Cell Res (2016) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse
In order to identify the source of obesity-induced MCP-1 and identify molecular regulators mediating MCP-1 production, Invitrogen Cd3g antibody (eBioscience, HMb1-1) was used in flow cytometry on mouse samples . Mol Metab (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; fig 1
In order to determine the affects of dendritic cell migration in vitro by loss of gadkin, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:100 (fig 1). PLoS ONE (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 1a
In order to explore the contributions of GATA3 to the group 3 innate lymphoid cells, Invitrogen Cd3g antibody (eBioscience, 2C11) was used in flow cytometry on mouse samples (fig 1a). Nat Immunol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...
In order to study how DNMT3A is involved in the function of PML-RARA, RUNX1-RUNX1T1, and MLL-AF9, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Clin Invest (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to study the roles caspase-11 and caspase-12 in obesity and insulin resistance, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 3
In order to study how DNAM-1 controls NK cell-mediated cytotoxicity and cytokine production, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 3). J Exp Med (2015) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse
In order to discuss methods to generate different T cell subsets in vitro, Invitrogen Cd3g antibody (eBiosciences, 2C11) was used in blocking or activating experiments on mouse samples . Methods Mol Biol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1c
In order to study the localization and function of CXCR2 in hepatocellular carcinoma, Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1c). J Exp Clin Cancer Res (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 6
In order to study the display of embryological defects and neonatal lethality despite normal lymphoid and non-lymphoid organogenesis, Invitrogen Cd3g antibody (eBioscience, 145-211) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 7
In order to study the contribution of IL-7 to pneumocystis pneumonia, Invitrogen Cd3g antibody (eBioscience, 25-0031-82) was used in flow cytometry on mouse samples (fig 7). Infect Immun (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 1c
Invitrogen Cd3g antibody (Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Nat Med (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2f
Invitrogen Cd3g antibody (eBioscience, 12-0031) was used in flow cytometry on mouse samples (fig 2f). J Exp Med (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:400
Invitrogen Cd3g antibody (eBioscience, 50-0032-82) was used in flow cytometry on mouse samples at 1:400. Nat Commun (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:250; tbl 1
In order to elucidate the prognosis of gastric cancer by tumor-infiltrating immune cells, Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:250 (tbl 1). Medicine (Baltimore) (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:200; fig 2
Invitrogen Cd3g antibody (eBioscience, 45-0031-82) was used in flow cytometry on mouse samples at 1:200 (fig 2). Nat Commun (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; fig 2
Invitrogen Cd3g antibody (eBioscience, 47-0032-82) was used in flow cytometry on mouse samples at 1:200 (fig 2). Nat Commun (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to show that RhoA controls homeostatic proliferation, cytokinesis, survival, and turnover of cDCs, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:500
In order to show that that both cell-mediated and humoral adaptive immune components are involved in photodynamic therapy, Invitrogen Cd3g antibody (eBioscience, 16003285) was used in immunohistochemistry on mouse samples at 1:500. Cell Mol Immunol (2017) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6a
In order to determine the effects of PD-0360324, a fully human immunoglobulin G2 monoclonal antibody against macrophage colony-stimulating factor, in patients with cutaneous lupus erythematosus, Invitrogen Cd3g antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 6a). Clin Exp Immunol (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:500; loading ...; fig 3c, 3d
Invitrogen Cd3g antibody (eBioscience, 12-0031) was used in flow cytometry on mouse samples at 1:500 (fig 3c, 3d). Endocrinology (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2g
In order to delineate the role of microRNA-21 in non-alcoholic steatohepatitis, Invitrogen Cd3g antibody (eBioscience, 17-0032-82) was used in flow cytometry on mouse samples (fig 2g). Gut (2016) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 5b
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen Cd3g antibody (eBiosciences, 45-2C11) was used in flow cytometry on mouse samples (fig 5b). Nat Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; fig 1f
  • flow cytometry; mouse; 1 ug/ml; fig 1b
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 1f) and in flow cytometry on mouse samples at 1 ug/ml (fig 1b). Nat Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5
In order to use peptidoglycan mimics to vaccinate against Staphylococcus aureus, Invitrogen Cd3g antibody (eBioscience, 11-C0031) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2015) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 5a
In order to determine the role of Syk in development of obliterative bronchiolitis, Invitrogen Cd3g antibody (EBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 5a). Am J Transplant (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s1a
In order to test if anti-retroviral natural killer cell functions are inhibited by T regulatory cells during an acute Friend retrovirus infection, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s1a). Retrovirology (2015) ncbi
Syrian golden hamster monoclonal (500A2)
  • flow cytometry; mouse; fig 1
In order to study how CCR2 regulates leukocyte mobilization from the bone marrow, Invitrogen Cd3g antibody (Caltag Laboratories, HM3421) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
In order to determine the periluminal distribution of CD4+ HIV target cells, Invitrogen Cd3g antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples (fig s1). PLoS ONE (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 2
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2). Cell Mol Immunol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; fig 4a
In order to determine the expression and function of HLA-G, HLA-G-regulatory microRNAs and the immune cell infiltration in renal cell carcinoma samples, Invitrogen Cd3g antibody (Thermo Scientific, MA1?C90582) was used in immunohistochemistry on human samples (fig 4a). Oncoimmunology (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s2
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s2). Leukemia (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to study mediation of TLR7-dependent inflammation and autoimmunity by B cell autophagy, Invitrogen Cd3g antibody (eBiosciences, 48-003280) was used in flow cytometry on mouse samples . Autophagy (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 1
Invitrogen Cd3g antibody (eBioscience, 12-0031-82) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human
Invitrogen Cd3g antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry on human samples . World J Urol (2016) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 1
In order to investigate the mechanisms that regulate the entrance and exit of immune cells from the central nervous system, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 1). Nature (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 2
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - paraffin section; human; fig 2
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, Invitrogen Cd3g antibody (ebiosciences, 145-2C11) was used in immunohistochemistry - paraffin section on human samples (fig 2). Nat Biotechnol (2015) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry; mouse; loading ...; fig 10b
In order to find that lymph node-like vasculature in melanoma and lung carcinoma murine models is both a consequence of and key contributor to anti-tumor immunity, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in immunohistochemistry on mouse samples (fig 10b). Nat Commun (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:100
Invitrogen Cd3g antibody (Lab Vision/NeoMarkers, SP7) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:100. PLoS ONE (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 4
In order to show that CD4 positive T cells and ILC2s together block Nippostrongylus brasiliensis development in the parenchyma, Invitrogen Cd3g antibody (eBiosciences, 2C11) was used in flow cytometry on mouse samples (fig 4). Nat Commun (2015) ncbi
rat monoclonal (17A2)
  • blocking or activating experiments; mouse
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in blocking or activating experiments on mouse samples . J Immunol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 7.5 ug/ml; loading ...; fig 6a
In order to develop an image analysis workflow to assess mouse colon cancer, Invitrogen Cd3g antibody (Thermo Scientific, RM-9107-S) was used in immunohistochemistry - paraffin section on mouse samples at 7.5 ug/ml (fig 6a). Vet Pathol (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; fig 4h
In order to identify a MCF2L variant linked to cardiovascular disease, Invitrogen Cd3g antibody (ThermoFischer, SP7) was used in immunohistochemistry on human samples (fig 4h). Eur J Hum Genet (2016) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:300; fig 1
In order to study the inhibition of extracellular CyPA in a mouse model of troponin I-induced autoimmune myocarditis, Invitrogen Cd3g antibody (Thermo Fisher Scientific, SP-7) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 1). PLoS ONE (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:12
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:12. PLoS ONE (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 3
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 3). J Exp Med (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunoprecipitation; mouse
  • immunohistochemistry; human
Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunoprecipitation on mouse samples and in immunohistochemistry on human samples . Dig Dis Sci (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100
Invitrogen Cd3g antibody (Lab Vision, SP7) was used in immunohistochemistry on human samples at 1:100. PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; fig 3
In order to analyze the effects of tumor growth and spread in two murine models with monocolonal antibodies to oncofetal antigen- an immature laminin receptor protein, Invitrogen Cd3g antibody (Thermo Scientific, RM9107-s) was used in immunohistochemistry on mouse samples (fig 3). Cancer Biol Ther (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 8
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 8). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig s3a
In order to study the role of STAT3 in KRAS mutant lung adenocarcinoma., Invitrogen Cd3g antibody (Neomarkers, RM9107) was used in immunohistochemistry on mouse samples at 1:100 (fig s3a). Nat Commun (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s1
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s1). Nat Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry; mouse; 1:100; fig 1
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in immunohistochemistry on mouse samples at 1:100 (fig 1). J Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 4
Invitrogen Cd3g antibody (eBioscience, 145-2c11) was used in flow cytometry on mouse samples (fig 4). Infect Immun (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 1
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 1
In order to elucidate the mechanisms by which RANKL promotes bone formation and erosion, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 1). J Bone Miner Res (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:25; loading ...; fig 2d
In order to study the effect of topical tenofovir gel in the rectal mucosa and primary vaginal cells., Invitrogen Cd3g antibody (Thermo Fisher Scientific, RM9107S) was used in immunohistochemistry on human samples at 1:25 (fig 2d). elife (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; tbl 1
In order to characterize histomorphometric tumors by induction of colorectal cancer in mice, Invitrogen Cd3g antibody (NeoMarkers, RM 9107) was used in immunohistochemistry - paraffin section on mouse samples (tbl 1). Methods Mol Biol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig s2
In order to elucidate the function of miR-29a in hematopoietic stem and progenitor cells, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples (fig s2). Blood (2015) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig 2
In order to assess the role of glycogen synthase kinase-3 in the production of IL-10 by CD4 positive T helper cells, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 2). Eur J Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 3
Invitrogen Cd3g antibody (ebioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 3). Proc Natl Acad Sci U S A (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5
Invitrogen Cd3g antibody (eBioscience (Affymetrix), 145-2C11) was used in flow cytometry on mouse samples (fig 5). J Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 2
In order to show how early events during viral infection decide the immune response and facilitate either control, clearance, or persistence of the virus, Invitrogen Cd3g antibody (eBioscience, 145-2c11) was used in flow cytometry on mouse samples (fig 2). PLoS Pathog (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; tbl 1
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (tbl 1). J Neuroinflammation (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 2
In order to assess the effects of Hspa9 haploinsufficiency on hematopoiesis using zebrafish, Invitrogen Cd3g antibody (BD/eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2). Exp Hematol (2015) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 1 ug/ml
In order to identify Cd8 cis-regulatory elements, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples at 1 ug/ml. J Leukoc Biol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - free floating section; human
Invitrogen Cd3g antibody (Lab Vision, SP7) was used in immunohistochemistry - free floating section on human samples . Arthritis Rheumatol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 1
Invitrogen Cd3g antibody (Ebioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1). Immunol Cell Biol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Development (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s1
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s1). J Leukoc Biol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples . J Am Heart Assoc (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples . Mucosal Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 5e
In order to investigate the application of intra-dermal mesoporous silica rods in immune modulation., Invitrogen Cd3g antibody (eBioscience, 25-0031) was used in flow cytometry on mouse samples (fig 5e). Nat Biotechnol (2015) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150
Invitrogen Cd3g antibody (Thermo Scientific Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:150. J Am Acad Dermatol (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; human; fig 2
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on human samples (fig 2). Clin Cancer Res (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig s3
Invitrogen Cd3g antibody (ebioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s3). J Natl Cancer Inst (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 1
In order to investigate the role of Rpl22 during early B cell development, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to examine the role of lymph node stromal cells in immune responses, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples . elife (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 1 ug/ml
  • flow cytometry; mouse; 1 ug/ml
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples at 1 ug/ml and in flow cytometry on mouse samples at 1 ug/ml. J Leukoc Biol (2015) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; fig 1e
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 1e). Nat Immunol (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5
In order to describe the pathogenesis of influenza A virus and Sendai virus in ISG15 knockout mice, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 5). J Virol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5
In order to determine the role of interferon regulatory factor 7 in Plasmodium berghei ANKA infection, Invitrogen Cd3g antibody (Life Technologies, 145-2C11) was used in flow cytometry on mouse samples (fig 5). Eur J Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2c11) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . Cancer Immunol Immunother (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:300
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples at 1:300. PLoS ONE (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150
Invitrogen Cd3g antibody (THERMO SC., SP7) was used in immunohistochemistry on human samples at 1:150. BMC Clin Pathol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to analyze deubiquitinization Usp9X and its regulation of proximal T cell receptor signaling and tolerance induction, Invitrogen Cd3g antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). J Exp Med (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; loading ...; fig 3c
In order to test the efficacy of combining different monoclonal antibodies to treat cancer, Invitrogen Cd3g antibody (ebioscience, 14-0031-82) was used in flow cytometry on mouse samples (fig 3c). Clin Cancer Res (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; human
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to study why HSC function declines with age, Invitrogen Cd3g antibody (eBioscience, 50-0032-82) was used in flow cytometry on mouse samples . Nature (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 25-0031-82) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s5
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s5). Mucosal Immunol (2015) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to investigate the effect of IgM-Fc receptor-ablation on autoimmunity, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to study Bacillus Calmette-Guerin DeltaureC::hly and the superior protection against tuberculosis caused by central memory CD4+ T cells, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Infect Dis (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; loading ...; fig s2c
In order to study the role of TH9 cells in ulcerative colitis, Invitrogen Cd3g antibody (eBioscience, 16-0031-85) was used in blocking or activating experiments on mouse samples (fig s2c). Nat Immunol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to study the relations between neurodegeneration, demyelination, inflammation, and iron in regards to multiple sclerosis, Invitrogen Cd3g antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000. J Neurol Neurosurg Psychiatry (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to explore the protective mechanism by which the oxysterol receptors suppress inflammatory bowel disease, Invitrogen Cd3g antibody (Labvision, RM-9107-S0) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Mucosal Immunol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Invitrogen Cd3g antibody (Fisher/Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse
Invitrogen Cd3g antibody (eBioscience, 25-0031-81) was used in immunohistochemistry - frozen section on mouse samples . Gene Ther (2014) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; fig 1
Invitrogen Cd3g antibody (eBioscience, 16-0031-81) was used in blocking or activating experiments on mouse samples (fig 1). PLoS ONE (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s1
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s1). PLoS Pathog (2014) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • immunohistochemistry - paraffin section; mouse; 1:100
Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Bone (2014) ncbi
rat monoclonal (17A2)
  • immunocytochemistry; human; tbl 2
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in immunocytochemistry on human samples (tbl 2). J Clin Invest (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (tbl 1). Nat Immunol (2014) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen Cd3g antibody (eBioscience, 500A2) was used in flow cytometry on mouse samples (tbl 1). Nat Immunol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
Invitrogen Cd3g antibody (Thermo Fisher Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples . Circ Arrhythm Electrophysiol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100
Invitrogen Cd3g antibody (Labvision/Thermo Scientific, SP7) was used in immunohistochemistry on human samples at 1:100. PLoS Pathog (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunocytochemistry; human; 1:100
Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunocytochemistry on human samples at 1:100. J Crohns Colitis (2014) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse
In order to investigate the effect of mechanical force on the T cell receptor, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples . J Immunol (2014) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; 5 ug/ml
Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in flow cytometry on mouse samples at 5 ug/ml. Immunology (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to elucidate mechanisms that regulate antimicrobial protein production by Paneth cells, Invitrogen Cd3g antibody (Caltag, 1452C11) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
hamsters monoclonal (145-2C11)
  • immunocytochemistry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in immunocytochemistry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (ebioscience, 17A2) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to determine optimal IL-17-inducing conditions using a vaccine and Mycobacterium tuberculosis challenge strategy, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to test if the epileptogenic mechanisms underlying Rasmussen encephalitis are related to changes in ADK expression, Invitrogen Cd3g antibody (Lab Vision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). J Neuropathol Exp Neurol (2013) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s1
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig s1). Nature (2013) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 1452C11) was used in flow cytometry on mouse samples . Stem Cells (2014) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; 1:100; fig s2
Invitrogen Cd3g antibody (eBioscience, 11-0031-82) was used in flow cytometry on mouse samples at 1:100 (fig s2). PLoS ONE (2013) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; fig 1
In order to determine if AID expression in the mouse extends beyond lymphocytes, Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2013) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; 1:1,000
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 14-0032-82) was used in immunohistochemistry - frozen section on mouse samples at 1:1,000 and in flow cytometry on mouse samples . J Comp Neurol (2013) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • blocking or activating experiments; mouse
In order to study the role of endothelial-to-mesenchymal transition in the onset and progression of cerebral cavernous malformations, Invitrogen Cd3g antibody (eBiosciences, 140033) was used in blocking or activating experiments on mouse samples . Nature (2013) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1
In order to investigate the mechanisms that lead to demyelination and neurodegeneration, Invitrogen Cd3g antibody (Neomarkers, RM-9107-S) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Brain (2013) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; tbl 2
In order to discuss how Epstein-Barr virus contributes to the development of small B-cell neoplasms, Invitrogen Cd3g antibody (Labvision, SP7) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). PLoS ONE (2012) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 10 ug/ml
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples at 10 ug/ml. J Immunol Methods (2013) ncbi
Syrian golden hamster monoclonal (500A2)
  • immunohistochemistry - frozen section; mouse; fig 2
In order to discuss 3D thymic reconstruction, Invitrogen Cd3g antibody (Invitrogen, clone 500A2) was used in immunohistochemistry - frozen section on mouse samples (fig 2). J Immunol (2013) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse
In order to study the kinetics of iNKT cell precursors, Invitrogen Cd3g antibody (Caltag Laboratories, 500-A2) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - frozen section; mouse; 1:50; fig s3
In order to report that TNFR1-independent prion accumulation in lymph nodes depends on LTbetaR signaling, Invitrogen Cd3g antibody (Thermoscientific, RM-9107-S1) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s3). PLoS Pathog (2012) ncbi
rat monoclonal (17A2)
  • flow cytometry; human; fig s9
Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on human samples (fig s9). PLoS Pathog (2012) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to determine how thermal processing influences ovalbumin's ability to induce allergic symptoms and immune responses in mouse model of food allergy, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 13-0031) was used in flow cytometry on mouse samples . Exp Hematol (2012) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to suggest that CD80 and CD86 contribute to polyclonal B cell activation mediated by Lat(Y136F) CD4 positive T cells, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Front Immunol (2012) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to study the contribution of IL-10 in mice infected with respiratory syncytial virus, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:100; fig 1
In order to test if damage to the lymphoid tissue fibroblastic reticular cell network contributes to naive T cell loss during HIV-1 infection, Invitrogen Cd3g antibody (Thermo Scientific, RM-9107-S1) was used in immunohistochemistry on human samples at 1:100 (fig 1). PLoS Pathog (2012) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; mouse
In order to characterize mammary cancers in multiparous Stat1 knockout mice, Invitrogen Cd3g antibody (Neomarkers, RM9107) was used in immunohistochemistry on mouse samples . Oncotarget (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 2
In order to evaluate the prognostic value of tumor-infiltrating lymphocytes in the anthracycline-based chemotherapy, Invitrogen Cd3g antibody (Lab Vision, RM-9107) was used in immunohistochemistry on human samples at 1:150 (fig 2). Breast Cancer Res (2011) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; dogs
Invitrogen Cd3g antibody (eBiosciences, 13003185) was used in flow cytometry on dogs samples . J Biol Chem (2012) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to determine the role for DOCK8 in peripheral CD8 T cell survival and function, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples . J Exp Med (2011) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 3
In order to examine Th17 cells in the microenvironment of primary intraocular B-cell lymphoma, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2011) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Haematologica (2011) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 3
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; loading ...
  • immunohistochemistry; human
In order to study three clinical cases of follicular dendritic cell sarcoma, Invitrogen Cd3g antibody (Thermo Scientific, SP7) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Hum Pathol (2012) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to discuss how to study activation-dependent phosphorylation of proteins using mathematical modeling, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 5C
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen Cd3g antibody (Thermo Scientific, RM-9107-S1) was used in immunohistochemistry on human samples at 1:150 (fig 5C). Proc Natl Acad Sci U S A (2012) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBioscience, ebio 47-0032) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; 1:150; tbl 2
In order to identify biomarkers to distinguish between true recurrence and new primary cases of ipsilateral breast tumor recurrence, Invitrogen Cd3g antibody (Lab vision, RM-9107) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Breast Cancer (Auckl) (2011) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5
In order to test if IL-17/IL-17 receptor-mediated responses contribute to T-cell-mediated concanavalin A-induced liver injury, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 5). Immunol Cell Biol (2012) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Invitrogen Cd3g antibody (Thermo, SP7) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Int J Surg Pathol (2014) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry - paraffin section; human; fig 3
  • immunohistochemistry; human
In order to investigate the localization of the prolactin receptor in atherosclerotic plaques, Invitrogen Cd3g antibody (Thermo Fisher, SP7) was used in immunohistochemistry - paraffin section on human samples (fig 3) and in immunohistochemistry on human samples . J Endocrinol (2011) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 4
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 4). J Immunol (2010) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; fig 4
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in flow cytometry on mouse samples (fig 4). J Immunol (2010) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; tbl 1
In order to develop and characterize a novel model of heterologous pulmonary infection using Bordetella parapertussis and influenza virus, Invitrogen Cd3g antibody (eBioscience, eBio500A2) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2010) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse; fig 1
In order to study the role of liver NK cells in virus-induced severe viral hepatitis, Invitrogen Cd3g antibody (eBioscience, 500A2) was used in flow cytometry on mouse samples (fig 1). J Immunol (2010) ncbi
Syrian golden hamster monoclonal (eBio500A2 (500A2))
  • flow cytometry; mouse
In order to elucidate the function of CD103 in the lung, Invitrogen Cd3g antibody (eBioscience, 500A2) was used in flow cytometry on mouse samples . Am J Pathol (2009) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 3
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 3). J Immunol (2009) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig s3
In order to study the role of bone marrow-derived cells in lymphangiogenesis, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2009) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
domestic rabbit monoclonal (SP7)
  • immunohistochemistry; human; 1:150; fig 1
In order to study autoantibodies and tumor-infiltrating T cells in epithelial ovarian cancer, Invitrogen Cd3g antibody (Lab Vision, RM-9107) was used in immunohistochemistry on human samples at 1:150 (fig 1). PLoS ONE (2008) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 0.1 ug/ml
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples at 0.1 ug/ml. Cell Res (2008) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; 5 ug/ml
In order to characterize the physiological consequences of ORAI1 deficiency, Invitrogen Cd3g antibody (Invitrogen, 2C11) was used in blocking or activating experiments on mouse samples at 5 ug/ml. Mol Cell Biol (2008) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to investigate whether hematopoietic cells transduce canonical Wnt signals in the absence of beta- and gamma-catenin, Invitrogen Cd3g antibody (eBioscience, 17A2) was used in flow cytometry on mouse samples . Blood (2008) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to quantify expression of Foxp3 on CD8+ T cells in the spleen during anterior chamber-associated immune deviation, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples . Mol Vis (2007) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 3
In order to determine the expression of CD39 in mouse and human T cells, Invitrogen Cd3g antibody (Invitrogen, 145.2C11) was used in flow cytometry on mouse samples (fig 3). Blood (2007) ncbi
Syrian golden hamster monoclonal (500A2)
  • blocking or activating experiments; mouse; 4 ug/ml
In order to evaluate the effect of adenosine 2A receptor agonists to attenuate allogenic immune activation, Invitrogen Cd3g antibody (Invitrogen Life Technologies, 500A2) was used in blocking or activating experiments on mouse samples at 4 ug/ml. J Immunol (2007) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse
In order to evaluate the effect of adenosine 2A receptor agonists to attenuate allogenic immune activation, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples . J Immunol (2007) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 2
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 2). J Virol (2006) ncbi
Syrian golden hamster monoclonal (500A2)
  • flow cytometry; mouse; fig 3
In order to characterize the role of CD4+ T cells and IFN-gamma and adenosine 2A receptor-mediated tissue protection and renal ischemia-reperfusion injury, Invitrogen Cd3g antibody (Caltag Laboratories, 500A2) was used in flow cytometry on mouse samples (fig 3). J Immunol (2006) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1). Int J Cancer (2006) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 5
In order to investigate how peroxide affects hematopoiesis, Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 5). Blood (2006) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 1
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in flow cytometry on mouse samples (fig 1). J Immunol (2005) ncbi
hamsters monoclonal (145-2C11)
  • immunohistochemistry - frozen section; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in immunohistochemistry - frozen section on mouse samples . Invest Ophthalmol Vis Sci (2005) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to evaluate the tuberculosis vaccine candidate Mtb72F, Invitrogen Cd3g antibody (eBiosciences, 145-2C11) was used in flow cytometry on mouse samples . Infect Immun (2005) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse
Invitrogen Cd3g antibody (eBioscience, 145-2C11) was used in blocking or activating experiments on mouse samples . Proc Natl Acad Sci U S A (2005) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; fig 2
In order to characterize the expression and function of 4-1BBL, Invitrogen Cd3g antibody (Caltag, 145-2C11) was used in flow cytometry on mouse samples (fig 2). Int Immunol (2002) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse
In order to assess the role of L-selectin in the pathogenesis of autoimmune diabetes, Invitrogen Cd3g antibody (caltag, 145 2C11) was used in flow cytometry on mouse samples . Eur J Immunol (1995) ncbi
Syrian golden hamster monoclonal (500A2)
  • flow cytometry; mouse
In order to determine the function of CD4+8+ thymocytes in thymic differentiation, Invitrogen Cd3g antibody (noco, 500A2) was used in flow cytometry on mouse samples . Nature (1987) ncbi
hamsters monoclonal (145-2C11)
  • flow cytometry; mouse; tbl 3
  • immunoprecipitation; mouse; fig 2
  • immunocytochemistry; mouse; fig 1
In order to identify T3-epsilon as a cell surface protein involved in the transduction of activation signals, Invitrogen Cd3g antibody (noco, 145-2C11) was used in flow cytometry on mouse samples (tbl 3), in immunoprecipitation on mouse samples (fig 2) and in immunocytochemistry on mouse samples (fig 1). Proc Natl Acad Sci U S A (1987) ncbi
hamsters monoclonal (145-2C11)
  • blocking or activating experiments; mouse; fig 2
In order to elucidate how 145-2C11 treatment results in kinase activation and CD3 phosphorylation, Invitrogen Cd3g antibody (noco, 145-2C11) was used in blocking or activating experiments on mouse samples (fig 2). J Immunol (1987) ncbi
Syrian golden hamster monoclonal (500A2)
  • blocking or activating experiments; mouse; 0.5-10 ug/ml; fig 1
In order to evaluate if an antibody-CD28 co-stimulatory signal blocks anergy induction in T-cell clones in mice, Invitrogen Cd3g antibody (noco, noca) was used in blocking or activating experiments on mouse samples at 0.5-10 ug/ml (fig 1). Nature (1992) ncbi
BioLegend
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Cd3g antibody (BioLegend, 100204) was used in flow cytometry on mouse samples at 1:200. elife (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Cd3g antibody (BioLegend, 100222) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 5f
BioLegend Cd3g antibody (Biolegend, 100217) was used in flow cytometry on mouse samples (fig 5f). Adv Sci (Weinh) (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2b, 2d, 2f
BioLegend Cd3g antibody (BioLegend, 100206) was used in flow cytometry on mouse samples (fig 2b, 2d, 2f). Sci Immunol (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:500; loading ...; fig e2e
BioLegend Cd3g antibody (BioLegend, 100222) was used in flow cytometry on mouse samples at 1:500 (fig e2e). Nat Cancer (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; fig 3b, 4b
BioLegend Cd3g antibody (BioLegend, 100246) was used in flow cytometry on mouse samples at 1:100 (fig 3b, 4b). Cell Rep (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5c
BioLegend Cd3g antibody (Biolegend, 100204) was used in flow cytometry on mouse samples at 1:100 (fig 5c). Front Pharmacol (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 1c, s3a, s3b, 4b
BioLegend Cd3g antibody (Biolegend, 100203) was used in flow cytometry on mouse samples at 1:100 (fig 1c, s3a, s3b, 4b). Development (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a, 5a
BioLegend Cd3g antibody (BioLegend, 100236) was used in flow cytometry on mouse samples at 1:200 (fig 3a, 5a). J Immunother Cancer (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1d, s2d
BioLegend Cd3g antibody (BioLegend, 100203) was used in flow cytometry on mouse samples (fig 1d, s2d). J Immunother Cancer (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1e, s1l, s5f, s5i
BioLegend Cd3g antibody (Biolegend, 100206) was used in flow cytometry on mouse samples (fig 1e, s1l, s5f, s5i). J Exp Med (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s20a
BioLegend Cd3g antibody (Biolegend, 100205) was used in flow cytometry on mouse samples (fig s20a). Nat Commun (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5s1
BioLegend Cd3g antibody (BioLegend, 100205) was used in flow cytometry on mouse samples at 1:100 (fig 5s1). elife (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; human; loading ...
BioLegend Cd3g antibody (BioLegend, 100214) was used in flow cytometry on human samples . J Clin Invest (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 6e
BioLegend Cd3g antibody (BioLegend, 100236) was used in flow cytometry on mouse samples (fig 6e). J Immunother Cancer (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s5c
BioLegend Cd3g antibody (BioLegend, 100218) was used in flow cytometry on mouse samples (fig s5c). J Clin Invest (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2a, 2b
BioLegend Cd3g antibody (Biolegend, 100236) was used in flow cytometry on mouse samples (fig 2a, 2b). Nat Commun (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend Cd3g antibody (Biolegend, 100203) was used in flow cytometry on mouse samples at 1:100. Nat Nanotechnol (2022) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Cd3g antibody (BioLegend, 100228) was used in flow cytometry on mouse samples (fig 2a). Front Oncol (2021) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3
BioLegend Cd3g antibody (BioLegend, 17A2) was used in immunohistochemistry on mouse samples at 1:100 (fig 3). Mol Psychiatry (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples (fig s5a). Signal Transduct Target Ther (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200
BioLegend Cd3g antibody (BioLegend, 100241) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples at 1:100. Antioxidants (Basel) (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 6a
BioLegend Cd3g antibody (Biolegend, 100219) was used in flow cytometry on mouse samples (fig 6a). Cell Death Dis (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100
BioLegend Cd3g antibody (BioLegend, 100206) was used in flow cytometry on mouse samples at 1:100. Brain Behav Immun (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...
BioLegend Cd3g antibody (BioLegend, 100232) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend Cd3g antibody (Biolegend, 100227) was used in flow cytometry on mouse samples (fig 3b). Int J Mol Sci (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend Cd3g antibody (BioLegend, 100237) was used in flow cytometry on mouse samples at 1:100. elife (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend Cd3g antibody (BioLegend, 100204) was used in flow cytometry on mouse samples (fig 5b). Am J Cancer Res (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 2s1g
BioLegend Cd3g antibody (BioLegend, 100232) was used in flow cytometry on mouse samples at 1:100 (fig 2s1g). elife (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Cd3g antibody (BioLegend, 100229) was used in flow cytometry on mouse samples (fig 1a). Mucosal Immunol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:150; loading ...; fig s4a
BioLegend Cd3g antibody (BioLegend, 100206) was used in flow cytometry on mouse samples at 1:150 (fig s4a). Nat Commun (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s1-1h
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples (fig s1-1h). elife (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig 5m
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples at 1:200 (fig 5m). Aging Cell (2021) ncbi
rat monoclonal (17A2)
  • immunocytochemistry; human; 1:100; loading ...; fig 6a
BioLegend Cd3g antibody (BioLegend, 100210) was used in immunocytochemistry on human samples at 1:100 (fig 6a). Nat Cancer (2021) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 3b
BioLegend Cd3g antibody (BioLegen, 100201) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 3b). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s5e
BioLegend Cd3g antibody (Biolegend, 100241) was used in flow cytometry on mouse samples (fig s5e). Cell (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; human; loading ...; fig s2c
BioLegend Cd3g antibody (Biolegend, 100236) was used in flow cytometry on human samples (fig s2c). Cell Death Dis (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2a, s2b, s2c
BioLegend Cd3g antibody (Biolegend, 100204) was used in flow cytometry on mouse samples (fig s2a, s2b, s2c). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...
BioLegend Cd3g antibody (BioLegend, 100212) was used in flow cytometry on mouse samples . Br J Cancer (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...
BioLegend Cd3g antibody (Biolegend, 100228) was used in flow cytometry on mouse samples . Commun Biol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...
BioLegend Cd3g antibody (Biolegend, 100205) was used in flow cytometry on mouse samples . Cell Rep (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3h
BioLegend Cd3g antibody (BioLegend, 100244) was used in flow cytometry on mouse samples at 1:200 (fig 3h). Transl Psychiatry (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Cd3g antibody (Biolegend, 100236) was used in flow cytometry on mouse samples (fig s1a). JCI Insight (2021) ncbi
rat monoclonal (17A2)
  • blocking or activating experiments; mouse; 2 ug/ml; fig 12f
BioLegend Cd3g antibody (BioLegend, 100201) was used in blocking or activating experiments on mouse samples at 2 ug/ml (fig 12f). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Cd3g antibody (Biolegend, 100222) was used in flow cytometry on mouse samples (fig 4a). Front Cell Dev Biol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s4
BioLegend Cd3g antibody (Biolegend, 100206) was used in flow cytometry on mouse samples (fig s4). Front Immunol (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
BioLegend Cd3g antibody (BioLegen, 100204) was used in flow cytometry on mouse samples . PLoS ONE (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig s8a
BioLegend Cd3g antibody (BioLegend, 100220) was used in flow cytometry on mouse samples at 1:200 (fig s8a). Nature (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 7a
BioLegend Cd3g antibody (BioLegend, 100203) was used in flow cytometry on mouse samples (fig 7a). Neoplasia (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s7c
BioLegend Cd3g antibody (Biolegend, 100237) was used in flow cytometry on mouse samples (fig s7c). Sci Adv (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples (fig 1a). Aging Cell (2021) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; loading ...
BioLegend Cd3g antibody (BioLegend, 100202) was used in immunohistochemistry on mouse samples . PLoS ONE (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:50; loading ...
BioLegend Cd3g antibody (Biolegend, 100249) was used in flow cytometry on mouse samples at 1:50. Nature (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1g
BioLegend Cd3g antibody (Biolegend, 100203) was used in flow cytometry on mouse samples (fig 1g). J Hematol Oncol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2a, 2e
BioLegend Cd3g antibody (Biolegend, 100236) was used in flow cytometry on mouse samples (fig 2a, 2e). Nat Commun (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Cd3g antibody (Biolegend, 100236) was used in flow cytometry on mouse samples (fig 4d). Theranostics (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s5e
BioLegend Cd3g antibody (Biolegend, 100221) was used in flow cytometry on mouse samples (fig s5e). Nat Commun (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 1c
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples (fig 1c). Mucosal Immunol (2021) ncbi
rat monoclonal (17A2)
  • flow cytometry; human; fig 3c
BioLegend Cd3g antibody (Biolegend, 100235) was used in flow cytometry on human samples (fig 3c). Nat Commun (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Cd3g antibody (BioLegend, 100229) was used in flow cytometry on mouse samples (fig s2a). Cell (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:250; loading ...; fig 4g
BioLegend Cd3g antibody (Biolegend, 100214) was used in flow cytometry on mouse samples at 1:250 (fig 4g). elife (2020) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 4f
BioLegend Cd3g antibody (BioLegend, 17A2) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 4f). J Clin Invest (2020) ncbi
rat monoclonal (17A2)
BioLegend Cd3g antibody (BioLegend, 17A2) was used . Nature (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig s5
BioLegend Cd3g antibody (Biolegend, 100205) was used in flow cytometry on mouse samples at 1:200 (fig s5). Nat Commun (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s17
BioLegend Cd3g antibody (BioLegend, 100201) was used in flow cytometry on mouse samples (fig s17). Nat Commun (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Cd3g antibody (Biolegend, 100222) was used in flow cytometry on mouse samples (fig 1c). Cell Rep (2020) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 5a
BioLegend Cd3g antibody (Biolegend, 100218) was used in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 5a). elife (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 4b, 4c, 4d
BioLegend Cd3g antibody (Biolegend, 100204) was used in flow cytometry on mouse samples (fig 4b, 4c, 4d). Front Cell Neurosci (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3, 5
BioLegend Cd3g antibody (BioLegend, 100222) was used in flow cytometry on mouse samples at 1:100 (fig 3, 5). Nat Commun (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:50; loading ...; fig 5d
BioLegend Cd3g antibody (BioLegend, 100210) was used in flow cytometry on mouse samples at 1:50 (fig 5d). Proc Natl Acad Sci U S A (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s3a, s3b, s3c, s4a
BioLegend Cd3g antibody (BioLegend, 100204) was used in flow cytometry on mouse samples (fig s3a, s3b, s3c, s4a). Cancers (Basel) (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s19a
BioLegend Cd3g antibody (Biolegend, 100213) was used in flow cytometry on mouse samples (fig s19a). Nat Commun (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s3a, s3b, s7c
BioLegend Cd3g antibody (Biolegend, 100215) was used in flow cytometry on mouse samples (fig s3a, s3b, s7c). Cell Rep (2019) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6
BioLegend Cd3g antibody (Biolegend, 100240) was used in immunohistochemistry on mouse samples at 1:100 (fig 6). JCI Insight (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2a, 2f
BioLegend Cd3g antibody (BioLegend, 100205) was used in flow cytometry on mouse samples (fig 2a, 2f). J Exp Med (2020) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 8a, s3a, s3b
BioLegend Cd3g antibody (Biolegend, 100222) was used in flow cytometry on mouse samples (fig 8a, s3a, s3b). J Clin Invest (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3a
BioLegend Cd3g antibody (Biolegend, 100220) was used in flow cytometry on mouse samples at 1:100 (fig 3a). elife (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig e6f
BioLegend Cd3g antibody (Biolegend, 100210) was used in flow cytometry on mouse samples at 1:100 (fig e6f). Nature (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig e3s, e3t
BioLegend Cd3g antibody (BioLegend, 100222) was used in flow cytometry on mouse samples at 1:200 (fig e3s, e3t). Nature (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples (fig 4d). J Clin Invest (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig s8a
BioLegend Cd3g antibody (Biolegend, 100241) was used in flow cytometry on mouse samples at 1:100 (fig s8a). Nat Commun (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Cd3g antibody (BioLegend, 100241) was used in flow cytometry on mouse samples (fig 3a). EMBO J (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2o
BioLegend Cd3g antibody (Biolegend, 100234) was used in flow cytometry on mouse samples (fig s2o). JCI Insight (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; fig e7b
BioLegend Cd3g antibody (Biolegend, 100216) was used in flow cytometry on mouse samples at 1:100 (fig e7b). Nature (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend Cd3g antibody (BioLegend, 100229) was used in flow cytometry on mouse samples (fig 2e). Immunity (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig sf8
BioLegend Cd3g antibody (Biolegend, 100218) was used in flow cytometry on mouse samples (fig sf8). Sci Rep (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig s1a, s2g
BioLegend Cd3g antibody (Biolegend, 100220) was used in flow cytometry on mouse samples at 1:100 (fig s1a, s2g). Nat Commun (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; human; 2.5 ug/ml; loading ...; fig 6d
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on human samples at 2.5 ug/ml (fig 6d). Cell Host Microbe (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 5 ug/ml; loading ...; fig s12
BioLegend Cd3g antibody (BioLegend, 100232) was used in flow cytometry on mouse samples at 5 ug/ml (fig s12). Science (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s7c
BioLegend Cd3g antibody (BioLegend, 100214) was used in flow cytometry on mouse samples (fig s7c). Cell Metab (2019) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3e
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend Cd3g antibody (Biolegend, 100228) was used in immunohistochemistry - frozen section on mouse samples (fig 3e) and in flow cytometry on mouse samples (fig 3b). Cell (2019) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Cd3g antibody (Biolegend, 100232) was used in flow cytometry on mouse samples (fig 3a). Nat Commun (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 2a, 3a
BioLegend Cd3g antibody (BioLegend, 100229) was used in flow cytometry on mouse samples (fig 2a, 3a). Cell (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:400; loading ...; fig 8c
BioLegend Cd3g antibody (BioLegend, 100235) was used in flow cytometry on mouse samples at 1:400 (fig 8c). Front Immunol (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Cd3g antibody (BioLegend, 100203) was used in flow cytometry on mouse samples (fig s2a). Cell (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig s4d
BioLegend Cd3g antibody (BioLegend, 100221) was used in flow cytometry on mouse samples at 1:200 (fig s4d). Nat Commun (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend Cd3g antibody (BioLegend, 100206) was used in flow cytometry on mouse samples (fig s2b). Mol Cell (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 2.5 ug/ml; loading ...; fig s4
BioLegend Cd3g antibody (Biolegend, 100221) was used in flow cytometry on mouse samples at 2.5 ug/ml (fig s4). Nat Commun (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2d
BioLegend Cd3g antibody (Biolegend, 100222) was used in flow cytometry on mouse samples (fig s2d). J Clin Invest (2018) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; loading ...; fig 2d
BioLegend Cd3g antibody (BioLegend, 100237) was used in immunohistochemistry on mouse samples (fig 2d). elife (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 2a
BioLegend Cd3g antibody (BioLegend, 100237) was used in flow cytometry on mouse samples (fig 2a). Cell (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; loading ...; fig 2a
BioLegend Cd3g antibody (Biolegend, 100204) was used in flow cytometry on mouse samples at 1:100 (fig 2a). Development (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Cd3g antibody (Biolegend, 100222) was used in flow cytometry on mouse samples (fig s2a). Nat Commun (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s10d
BioLegend Cd3g antibody (BioLegend, 100236) was used in flow cytometry on mouse samples (fig s10d). Nature (2018) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s4a
BioLegend Cd3g antibody (BioLegend, 100203) was used in flow cytometry on mouse samples (fig s4a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig s7e
BioLegend Cd3g antibody (Biolegend, 100235) was used in flow cytometry on mouse samples at 1:200 (fig s7e). Nat Cell Biol (2017) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; loading ...; fig 3c
In order to study the involvement of the Ox40/Ox40 ligand pathway in systemic lupus erythematosus, BioLegend Cd3g antibody (BioLegend, 100214) was used in immunohistochemistry on mouse samples (fig 3c). J Immunol (2017) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s2d
In order to study the impact of granulocyte/macrophage progenitor on myelopoiesis and leukemia, BioLegend Cd3g antibody (BioLegend, 100210) was used in immunohistochemistry - frozen section on mouse samples (fig s2d). Nature (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3
In order to examine B cell homeostasis modifications in an experimental model of systemic sclerosis, BioLegend Cd3g antibody (BioLegend, 100219) was used in flow cytometry on mouse samples at 1:200 (fig 3). Front Immunol (2017) ncbi
rat monoclonal (17A2)
  • immunohistochemistry; mouse; loading ...; fig s1d
In order to evaluate host immune-mediated cell rejection in a retinal transplantation model, BioLegend Cd3g antibody (Biolegend, 100243) was used in immunohistochemistry on mouse samples (fig s1d). Cell Stem Cell (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:80; loading ...
In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, BioLegend Cd3g antibody (Biolegend, 100237) was used in flow cytometry on mouse samples at 1:80. Nat Commun (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s1a
In order to characterize Aire-mediated signaling in medullary thymic epithelial cells, BioLegend Cd3g antibody (BioLegend, 100218) was used in flow cytometry on mouse samples (fig s1a). Nat Immunol (2017) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 1G
In order to study epigenetic heterogeneity in hematopoietic stem cells., BioLegend Cd3g antibody (Biolegend, 100236) was used in flow cytometry on mouse samples (fig 1G). Cell (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig s7
In order to study CD153+ PD-1+ CD44hi CD4+ T cells in the visceral adipose tissue of high fat diet-fed obese mice, BioLegend Cd3g antibody (BioLegend, 14A-2) was used in flow cytometry on mouse samples (fig s7). J Clin Invest (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend Cd3g antibody (BioLegend, 100222) was used in flow cytometry on mouse samples (fig 1). Cell (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; rat; fig 6
BioLegend Cd3g antibody (Biolegend, 100205) was used in flow cytometry on rat samples (fig 6). J Neuroinflammation (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:50; loading ...; fig s9d
In order to investigate if CRISPR-Cas9 delivery by adeno-associated virus induces an immune response, BioLegend Cd3g antibody (BioLegend, 100220) was used in flow cytometry on mouse samples at 1:50 (fig s9d). Nat Methods (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100; fig 1
BioLegend Cd3g antibody (BioLegend, 100204) was used in flow cytometry on mouse samples at 1:100 (fig 1). Exp Ther Med (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 6
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 5
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples (fig 5). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2j
In order to use Disheveled knockout mice to study the role of Wnt signaling in gastrointestinal homeostasis, BioLegend Cd3g antibody (BioLegend, 100240) was used in immunohistochemistry - frozen section on mouse samples (fig 2j). JCI Insight (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig s2d
BioLegend Cd3g antibody (Biolegend, 100204) was used in flow cytometry on mouse samples (fig s2d). Nat Commun (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 3
In order to report that vaccine-induced T regulatory cells aid to control de novo primed autoreactive effector CD8(+) T cells in a diabetes model, BioLegend Cd3g antibody (BioLegend, 100205) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 5
BioLegend Cd3g antibody (BioLegend, 17-2) was used in flow cytometry on mouse samples (fig 5). Science (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to investigate the effects of IL-1 on hematopoietic stem cells, BioLegend Cd3g antibody (BioLegend, 100202) was used in flow cytometry on mouse samples . Nat Cell Biol (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 8a
BioLegend Cd3g antibody (BioLegend, 100214) was used in flow cytometry on mouse samples (fig 8a). J Biol Chem (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples . Oncotarget (2016) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - paraffin section; mouse; 1:300; fig 9
BioLegend Cd3g antibody (BioLegend, I7A2) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 9). PLoS ONE (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 1
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2016) ncbi
rat monoclonal (17A2)
  • blocking or activating experiments; mouse; fig 3
  • flow cytometry; mouse; fig 3
In order to examine the effect of 4-methylumbelliferone treatment on experimental autoimmune encephalomyelitis, BioLegend Cd3g antibody (Biolegend, 17A2) was used in blocking or activating experiments on mouse samples (fig 3) and in flow cytometry on mouse samples (fig 3). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 3
In order to study dendritic cells in Sirt6 knock out mice, BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples (fig 3). Aging (Albany NY) (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:100
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples at 1:100. Nature (2016) ncbi
rat monoclonal (17A2)
BioLegend Cd3g antibody (Biolegend, 100218) was used . Sci Rep (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 2
BioLegend Cd3g antibody (biolegend, 17A2) was used in flow cytometry on mouse samples (fig 2). Theranostics (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 4
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples (fig 4). Mucosal Immunol (2016) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:500; fig s2
BioLegend Cd3g antibody (BioLegend, 100218) was used in flow cytometry on mouse samples at 1:500 (fig s2). Nat Commun (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
BioLegend Cd3g antibody (Biolegend, 17A2) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (17A2)
  • immunohistochemistry - paraffin section; mouse
BioLegend Cd3g antibody (BioLegend, 100210) was used in immunohistochemistry - paraffin section on mouse samples . Cardiovasc Res (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; fig 3B
In order to report a B cell-intrinsic role for Rab7, BioLegend Cd3g antibody (BioLegend, 100204) was used in flow cytometry on mouse samples (fig 3B). J Immunol (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
In order to show that MDSCs promote invasion of mammary carcinoma cells by increasing fibroblast migration, BioLegend Cd3g antibody (Biolegend, 100203) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; 1:200
In order to report that autophaghy regulates NFkapaB activity through A20 sequestration, BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Cd3g antibody (biolegend, 100235) was used in flow cytometry on mouse samples (fig 6a). Appl Microbiol Biotechnol (2015) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (17A2)
  • flow cytometry; mouse
BioLegend Cd3g antibody (BioLegend, 17A2) was used in flow cytometry on mouse samples . Dis Model Mech (2014) ncbi
rat monoclonal (17A2)
BioLegend Cd3g antibody (Biolegend, 100222) was used . J Vis Exp (2014) ncbi
Bio-Rad
rat monoclonal (KT3)
  • immunohistochemistry; mouse; 1:200; loading ...; fig s6a
Bio-Rad Cd3g antibody (Bio-Rad, MCA500GT) was used in immunohistochemistry on mouse samples at 1:200 (fig s6a). Proc Natl Acad Sci U S A (2022) ncbi
rat monoclonal (KT3)
  • immunohistochemistry - paraffin section; mouse; fig 5
Bio-Rad Cd3g antibody (AbD Serotec, KT3) was used in immunohistochemistry - paraffin section on mouse samples (fig 5). Cell Death Dis (2016) ncbi
rat monoclonal (KT3)
  • immunohistochemistry - paraffin section; mouse; 1:300; fig 4
Bio-Rad Cd3g antibody (Serotec, MCA500G) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 4). Oncotarget (2016) ncbi
rat monoclonal (KT3)
  • immunohistochemistry; mouse; 1:50; fig 4d
In order to assess lung emphysema and predisposition due to extracellular matrix defects in aneurysmal Fibulin-4 mice, Bio-Rad Cd3g antibody (AbD Serotec, KT3) was used in immunohistochemistry on mouse samples at 1:50 (fig 4d). PLoS ONE (2014) ncbi
rat monoclonal (KT3)
  • immunohistochemistry; mouse
Bio-Rad Cd3g antibody (Serotec, MCA500G) was used in immunohistochemistry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (KT3)
  • immunocytochemistry; mouse; 1:200
Bio-Rad Cd3g antibody (Serotec, MCA500GA) was used in immunocytochemistry on mouse samples at 1:200. Nat Med (2013) ncbi
Articles Reviewed
  1. Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13:5782 pubmed publisher
  2. Gawish R, Maier B, Obermayer G, Watzenboeck M, Gorki A, Quattrone F, et al. A neutrophil-B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4. elife. 2022;11: pubmed publisher
  3. Zhao F, Zhang C, Li G, Zheng H, Gu L, Zhou H, et al. A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease. Front Immunol. 2022;13:873720 pubmed publisher
  4. Lin J, Lv J, Yu S, Chen Y, Wang H, Chen J. Transcript Engineered Extracellular Vesicles Alleviate Alloreactive Dynamics in Renal Transplantation. Adv Sci (Weinh). 2022;9:e2202633 pubmed publisher
  5. Xu D, Ma R, Ju Y, Song X, Niu B, Hong W, et al. Cholesterol sulfate alleviates ulcerative colitis by promoting cholesterol biosynthesis in colonic epithelial cells. Nat Commun. 2022;13:4428 pubmed publisher
  6. Selle J, Dinger K, Jentgen V, Zanetti D, Will J, Georgomanolis T, et al. Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life. Nat Commun. 2022;13:4352 pubmed publisher
  7. Tosti E, Almeida A, Tran T, Barbachan E Silva M, Broin P, Dubin R, et al. Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer. Cell Mol Gastroenterol Hepatol. 2022;14:693-717 pubmed publisher
  8. Lu L, Li T, Feng X, Liu Z, Liu Y, Chao T, et al. Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice. PLoS Pathog. 2022;18:e1010596 pubmed publisher
  9. Yang K, Han J, Gill J, Park J, Sathe M, Gattineni J, et al. The mammalian SKIV2L RNA exosome is essential for early B cell development. Sci Immunol. 2022;7:eabn2888 pubmed publisher
  10. Liu X, Viswanadhapalli S, Kumar S, Lee T, Moore A, Ma S, et al. Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress. Nat Cancer. 2022;: pubmed publisher
  11. Deal B, Reynolds L, PATTERSON C, Janjic J, Pollock J. Behavioral and inflammatory sex differences revealed by celecoxib nanotherapeutic treatment of peripheral neuroinflammation. Sci Rep. 2022;12:8472 pubmed publisher
  12. Taniguchi H, Caeser R, Chavan S, Zhan Y, Chow A, Manoj P, et al. WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC. Cell Rep. 2022;39:110814 pubmed publisher
  13. Zhang R, Wang Y, Liu D, Luo Q, Du P, Zhang H, et al. Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice. Front Pharmacol. 2022;13:870848 pubmed publisher
  14. Saxena V, Piao W, Li L, Paluskievicz C, Xiong Y, Simon T, et al. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Rep. 2022;39:110727 pubmed publisher
  15. Meléndez E, Chondronasiou D, Mosteiro L, Mart xed nez de Villarreal J, Fern xe1 ndez Alfara M, Lynch C, et al. Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development. 2022;149: pubmed publisher
  16. Zhang Y, Huo F, Cao Q, Jia R, Huang Q, Wang Z, et al. FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. J Immunother Cancer. 2022;10: pubmed publisher
  17. Tang T, Huang X, Zhang G, Lu M, Hong Z, Wang M, et al. Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis. J Immunother Cancer. 2022;10: pubmed publisher
  18. Liu M, Wu C, Luo S, Hua Q, Chen H, Weng Y, et al. PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen. J Exp Med. 2022;219: pubmed publisher
  19. Sibilio A, Suñer C, Fernández Alfara M, Martín J, Berenguer A, Calon A, et al. Immune translational control by CPEB4 regulates intestinal inflammation resolution and colorectal cancer development. iScience. 2022;25:103790 pubmed publisher
  20. Araujo A, Abaurrea A, Azcoaga P, L xf3 pez Velazco J, Manzano S, Rodriguez J, et al. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. J Clin Invest. 2022;132: pubmed publisher
  21. Zheng W, Feng Y, Zeng Z, Ye M, Wang M, Liu X, et al. Choroid plexus-selective inactivation of adenosine A2A receptors protects against T cell infiltration and experimental autoimmune encephalomyelitis. J Neuroinflammation. 2022;19:52 pubmed publisher
  22. Zhang M, Cui J, Lee D, Yuen V, Chiu D, Goh C, et al. Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer. Nat Commun. 2022;13:954 pubmed publisher
  23. Li M, Ong C, Langou xeb t Astri xe9 C, Tan L, Verma A, Yang Y, et al. Heparan sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE. elife. 2022;11: pubmed publisher
  24. Yang B, Zhang Z, Chen X, Wang X, Qin S, Du L, et al. An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment. J Clin Invest. 2022;132: pubmed publisher
  25. Thakkar D, Paliwal S, Dharmadhikari B, Guan S, Liu L, Kar S, et al. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner. J Immunother Cancer. 2022;10: pubmed publisher
  26. Guo X, Kimura A, Namekata K, Harada C, Arai N, Takeda K, et al. ASK1 signaling regulates phase-specific glial interactions during neuroinflammation. Proc Natl Acad Sci U S A. 2022;119: pubmed publisher
  27. Almishri W, Swain L, D Mello C, Le T, Urbanski S, Nguyen H. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice. Front Immunol. 2021;12:779119 pubmed publisher
  28. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  29. Yang K, Han J, Asada M, Gill J, Park J, Sathe M, et al. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease. J Clin Invest. 2022;132: pubmed publisher
  30. Du Y, Peng Q, Cheng D, Pan T, Sun W, Wang H, et al. Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells. Nat Commun. 2022;13:231 pubmed publisher
  31. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  32. Bristow C, Reeves M, Winston R. Alphataxin, a Small-Molecule Drug That Elevates Tumor-Infiltrating CD4+ T Cells, in Combination With Anti-PD-1 Therapy, Suppresses Murine Renal Cancer and Metastasis. Front Oncol. 2021;11:739080 pubmed publisher
  33. Zhou Q, Liang J, Yang T, Liu J, Li B, Li Y, et al. Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO Mol Med. 2022;14:e14502 pubmed publisher
  34. Arinrad S, Wilke J, Seelbach A, Doeren J, Hindermann M, Butt U, et al. NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance. Mol Psychiatry. 2021;: pubmed publisher
  35. Fahy N, Palomares Cabeza V, Lolli A, Witte Bouma J, Merino A, Ridwan Y, et al. Chondrogenically Primed Human Mesenchymal Stem Cells Persist and Undergo Early Stages of Endochondral Ossification in an Immunocompetent Xenogeneic Model. Front Immunol. 2021;12:715267 pubmed publisher
  36. Jiang Y, Yuan Y, Chen M, Li S, Bai J, Zhang Y, et al. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression. Theranostics. 2021;11:9162-9176 pubmed publisher
  37. Liu Y, Du J, Liu X, Wang L, Han Y, Huang C, et al. MG149 inhibits histone acetyltransferase KAT8-mediated IL-33 acetylation to alleviate allergic airway inflammation and airway hyperresponsiveness. Signal Transduct Target Ther. 2021;6:321 pubmed publisher
  38. Malenica I, Adam J, Corgnac S, Mezquita L, Auclin E, Damei I, et al. Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade. Nat Commun. 2021;12:5209 pubmed publisher
  39. Neumann S, Campbell K, Woodall M, Evans M, Clarkson A, Young S. Obesity Has a Systemic Effect on Immune Cells in Naïve and Cancer-Bearing Mice. Int J Mol Sci. 2021;22: pubmed publisher
  40. Cortés A, Solas M, Pejenaute A, Abellanas M, Garcia Lacarte M, Aymerich M, et al. Expression of Endothelial NOX5 Alters the Integrity of the Blood-Brain Barrier and Causes Loss of Memory in Aging Mice. Antioxidants (Basel). 2021;10: pubmed publisher
  41. Zhang Y, McGrath K, Ayoub E, Kingsley P, Yu H, Fegan K, et al. Mds1CreERT2, an inducible Cre allele specific to adult-repopulating hematopoietic stem cells. Cell Rep. 2021;36:109562 pubmed publisher
  42. Xu P, Xiong W, Lin Y, Fan L, Pan H, Li Y. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression. Cell Death Dis. 2021;12:779 pubmed publisher
  43. Tillie R, Theelen T, van Kuijk K, Temmerman L, de Bruijn J, Gijbels M, et al. A Switch from Cell-Associated to Soluble PDGF-B Protects against Atherosclerosis, despite Driving Extramedullary Hematopoiesis. Cells. 2021;10: pubmed publisher
  44. Dhawan U, Bhattacharya P, Narayanan S, Manickam V, Aggarwal A, Subramanian M. Hypercholesterolemia Impairs Clearance of Neutrophil Extracellular Traps and Promotes Inflammation and Atherosclerotic Plaque Progression. Arterioscler Thromb Vasc Biol. 2021;41:2598-2615 pubmed publisher
  45. Hoffman R, Huang S, Chalasani G, Vallejo A. Disparate Recruitment and Retention of Plasmacytoid Dendritic Cells to The Small Intestinal Mucosa between Young and Aged Mice. Aging Dis. 2021;12:1183-1196 pubmed publisher
  46. Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, et al. Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis. Sci Rep. 2021;11:15075 pubmed publisher
  47. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  48. Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36:109412 pubmed publisher
  49. Olson B, Zhu X, Norgard M, Diba P, Levasseur P, Buenafe A, et al. Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment. Brain Behav Immun. 2021;97:102-118 pubmed publisher
  50. Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs J, Wawrzyniak M, et al. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci. 2021;22: pubmed publisher
  51. Gehlsen U, Stary D, Maass M, Riesner K, Musial G, Stern M, et al. Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis. Int J Mol Sci. 2021;22: pubmed publisher
  52. Al Ani M, Elemam N, Hachim I, Raju T, Muhammad J, Hachim M, et al. Molecular Examination of Differentially Expressed Genes in the Brains of Experimental Autoimmune Encephalomyelitis Mice Post Herceptin Treatment. J Inflamm Res. 2021;14:2601-2617 pubmed publisher
  53. Ryu S, Shchukina I, Youm Y, Qing H, Hilliard B, Dlugos T, et al. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. elife. 2021;10: pubmed publisher
  54. Lacy M, Burger C, Shami A, Ahmadsei M, Winkels H, Nitz K, et al. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease. Nat Commun. 2021;12:3754 pubmed publisher
  55. Wang J, Zhang Y, Xiao Y, Yuan X, Li P, Wang X, et al. Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer. Am J Cancer Res. 2021;11:2005-2024 pubmed
  56. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  57. Zhang X, Liu X, Zhou W, Du Q, Yang M, Ding Y, et al. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance. Cell Mol Gastroenterol Hepatol. 2021;12:1179-1199 pubmed publisher
  58. Oikonomou N, Schuijs M, Chatzigiagkos A, Androulidaki A, Aidinis V, Hammad H, et al. Airway epithelial cell necroptosis contributes to asthma exacerbation in a mouse model of house dust mite-induced allergic inflammation. Mucosal Immunol. 2021;14:1160-1171 pubmed publisher
  59. Zimmer T, Broekaart D, Luinenburg M, Mijnsbergen C, Anink J, Sim N, et al. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol. 2021;47:826-839 pubmed publisher
  60. Glassman C, Su L, Majri Morrison S, Winkelmann H, Mo F, Li P, et al. Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist. elife. 2021;10: pubmed publisher
  61. Roca C, Burton O, Gergelits V, Prezzemolo T, Whyte C, Halpert R, et al. AutoSpill is a principled framework that simplifies the analysis of multichromatic flow cytometry data. Nat Commun. 2021;12:2890 pubmed publisher
  62. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  63. Kalinina A, Khromykh L, Kazansky D, Deykin A, Silaeva Y. Suppression of the Immune Response by Syngeneic Splenocytes Adoptively Transferred to Sublethally Irradiated Mice. Acta Naturae. 2021;13:116-126 pubmed publisher
  64. Lin Q, Rong L, Jia X, Li R, Yu B, Hu J, et al. IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun. 2021;12:2537 pubmed publisher
  65. Geng G, Liu J, Xu C, Pei Y, Chen L, Mu C, et al. Receptor-mediated mitophagy regulates EPO production and protects against renal anemia. elife. 2021;10: pubmed publisher
  66. Piñeiro Hermida S, Martinez P, Blasco M. Short and dysfunctional telomeres protect from allergen-induced airway inflammation. Aging Cell. 2021;20:e13352 pubmed publisher
  67. Flamini S, Sergeev P, Viana de Barros Z, Mello T, Biagioli M, Paglialunga M, et al. Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment. Cell Death Dis. 2021;12:421 pubmed publisher
  68. Morel K, Sheahan A, Burkhart D, Baca S, Boufaied N, Liu Y, et al. EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer. Nat Cancer. 2021;2:444-456 pubmed publisher
  69. Go D, Lee S, Lee S, Woo S, Kim K, Kim K, et al. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis. Cell Mol Gastroenterol Hepatol. 2021;12:715-739 pubmed publisher
  70. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  71. Lake C, Voss K, Bauman B, Pohida K, Jiang T, Dveksler G, et al. TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1. Cell Death Dis. 2021;12:400 pubmed publisher
  72. Zheng W, Song H, Luo Z, Wu H, Chen L, Wang Y, et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  73. Akgul A, Maddaloni M, Jun S, Nelson A, Odreman V, Hoffman C, et al. Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren's syndrome. Arthritis Res Ther. 2021;23:99 pubmed publisher
  74. Lisk C, Yuen R, Kuniholm J, Antos D, Reiser M, Wetzler L. CD169+ Subcapsular Macrophage Role in Antigen Adjuvant Activity. Front Immunol. 2021;12:624197 pubmed publisher
  75. Joseph R, Soundararajan R, Vasaikar S, Yang F, Allton K, Tian L, et al. CD8+ T cells inhibit metastasis and CXCL4 regulates its function. Br J Cancer. 2021;125:176-189 pubmed publisher
  76. Barcia Durán J, Lu T, Houghton S, Geng F, Schreiner R, Xiang J, et al. Endothelial Jak3 expression enhances pro-hematopoietic angiocrine function in mice. Commun Biol. 2021;4:406 pubmed publisher
  77. Sewastianik T, Straubhaar J, Zhao J, Samur M, Adler K, Tanton H, et al. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms. Blood. 2021;137:1905-1919 pubmed publisher
  78. Fallon E, Chung C, Heffernan D, Chen Y, De Paepe M, Ayala A. Survival and Pulmonary Injury After Neonatal Sepsis: PD1/PDL1's Contributions to Mouse and Human Immunopathology. Front Immunol. 2021;12:634529 pubmed publisher
  79. Goncalves S, Yin K, Ito Y, Chan A, Olan I, Gough S, et al. COX2 regulates senescence secretome composition and senescence surveillance through PGE2. Cell Rep. 2021;34:108860 pubmed publisher
  80. Beins E, Beiert T, Jenniches I, Hansen J, Leidmaa E, Schrickel J, et al. Cannabinoid receptor 1 signalling modulates stress susceptibility and microglial responses to chronic social defeat stress. Transl Psychiatry. 2021;11:164 pubmed publisher
  81. Berg N, Li J, Kim B, Mills T, Pei G, Zhao Z, et al. Hypoxia-inducible factor-dependent induction of myeloid-derived netrin-1 attenuates natural killer cell infiltration during endotoxin-induced lung injury. FASEB J. 2021;35:e21334 pubmed publisher
  82. Xiao Y, Shu L, Wu X, Liu Y, Cheong L, Liao B, et al. Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages. JCI Insight. 2021;6: pubmed publisher
  83. Mao F, Lv Y, Hao C, Teng Y, Liu Y, Cheng P, et al. Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense. Cell Mol Gastroenterol Hepatol. 2021;12:395-425 pubmed publisher
  84. Santos Zas I, Lemari xe9 J, Zlatanova I, Cachanado M, Seghezzi J, Benamer H, et al. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021;12:1483 pubmed publisher
  85. Zheng H, Zhang Y, Li L, Zhang R, Luo Z, Yang Z, et al. Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosis After Ischemia-Reperfusion Injury. Front Cell Dev Biol. 2021;9:641527 pubmed publisher
  86. Zarb Y, Sridhar S, Nassiri S, Utz S, Schaffenrath J, Maheshwari U, et al. Microglia control small vessel calcification via TREM2. Sci Adv. 2021;7: pubmed publisher
  87. Guo S, Smeltz R, Nanajian A, Heller R. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models. Front Immunol. 2020;11:614667 pubmed publisher
  88. Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, et al. Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell. 2021;12:240-260 pubmed publisher
  89. Song L, Chang R, Sun X, Lu L, Gao H, Lu H, et al. Macrophage-derived EDA-A2 inhibits intestinal stem cells by targeting miR-494/EDA2R/β-catenin signaling in mice. Commun Biol. 2021;4:213 pubmed publisher
  90. Ballet R, Brennan M, Brandl C, Feng N, Berri J, Cheng J, et al. A CD22-Shp1 phosphatase axis controls integrin β7 display and B cell function in mucosal immunity. Nat Immunol. 2021;22:381-390 pubmed publisher
  91. Ali S, Borin T, Piranlioglu R, Ara R, Lebedyeva I, Angara K, et al. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study. PLoS ONE. 2021;16:e0246646 pubmed publisher
  92. Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed publisher
  93. Wang F, Ye W, Wang S, He Y, Zhong H, Wang Y, et al. Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy. Neoplasia. 2021;23:281-293 pubmed publisher
  94. Malone K, Diaz Diaz A, Shearer J, Moore A, Waeber C. The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia. J Neuroinflammation. 2021;18:37 pubmed publisher
  95. Phan T, Schink L, Mann J, Merk V, Zwicky P, Mundt S, et al. Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids. Sci Adv. 2021;7: pubmed publisher
  96. Nian Y, Iske J, Maenosono R, Minami K, Heinbokel T, Quante M, et al. Targeting age-specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survival. Aging Cell. 2021;20:e13299 pubmed publisher
  97. Karhadkar T, Pilling D, Gomer R. Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice. PLoS ONE. 2021;16:e0245924 pubmed publisher
  98. Aslam M, Alemdehy M, Kwesi Maliepaard E, Muhaimin F, Caganova M, Pardieck I, et al. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation. EMBO Rep. 2021;22:e51184 pubmed publisher
  99. Sanmarco L, Wheeler M, Gutiérrez Vázquez C, Polonio C, Linnerbauer M, Pinho Ribeiro F, et al. Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes. Nature. 2021;: pubmed publisher
  100. Kaur S, Sehgal A, Wu A, Millard S, Batoon L, Sandrock C, et al. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice. J Hematol Oncol. 2021;14:3 pubmed publisher
  101. Khaw Y, Majid D, Oh S, Kang E, Inoue M. Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling. Nat Commun. 2021;12:105 pubmed publisher
  102. Suah A, Tran D, Khiew S, Andrade M, Pollard J, Jain D, et al. Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021;131: pubmed publisher
  103. Hu Z, Luo C, Hurtado P, Li H, Wang S, Hu B, et al. Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis. Theranostics. 2021;11:715-730 pubmed publisher
  104. Luo R, Cheng Y, Chang D, Liu T, Liu L, Pei G, et al. Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A. Theranostics. 2021;11:117-131 pubmed publisher
  105. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  106. Li X, Zhang M, Huang X, Liang W, Li G, Lu X, et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat Commun. 2020;11:6364 pubmed publisher
  107. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  108. Gao L, Li B, Wang J, Shen D, Yang M, Sun R, et al. Activation of Liver X Receptor α Sensitizes Mice to T-Cell Mediated Hepatitis. Hepatol Commun. 2020;4:1664-1679 pubmed publisher
  109. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed publisher
  110. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  111. Ricci B, Tycksen E, Celik H, Belle J, Fontana F, Civitelli R, et al. Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics. elife. 2020;9: pubmed publisher
  112. Florian M, Leins H, Gobs M, Han Y, Marka G, Soller K, et al. Inhibition of Cdc42 activity extends lifespan and decreases circulating inflammatory cytokines in aged female C57BL/6 mice. Aging Cell. 2020;:e13208 pubmed publisher
  113. Li Z, Zhang H, Huang Y, Huang J, Sun P, Zhou N, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806 pubmed publisher
  114. Piersma S, Poursine Laurent J, Yang L, Barber G, Parikh B, Yokoyama W. Virus infection is controlled by hematopoietic and stromal cell sensing of murine cytomegalovirus through STING. elife. 2020;9: pubmed publisher
  115. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  116. Bhaskar A, Kumar S, Khan M, Singh A, Dwivedi V, Nandicoori V. Host sirtuin 2 as an immunotherapeutic target against tuberculosis. elife. 2020;9: pubmed publisher
  117. Harbour S, DiToro D, Witte S, Zindl C, Gao M, Schoeb T, et al. TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci Immunol. 2020;5: pubmed publisher
  118. Lubos N, van der Gaag S, Gerçek M, Kant S, Leube R, Krusche C. Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020;115:42 pubmed publisher
  119. Cao W, Fang F, Gould T, Li X, Kim C, Gustafson C, et al. Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation. J Clin Invest. 2020;130:3422-3436 pubmed publisher
  120. Yamamoto K, Venida A, Yano J, Biancur D, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100-105 pubmed publisher
  121. Deng M, Tam J, Wang L, Liang K, Li S, Zhang L, et al. TRAF3IP3 negatively regulates cytosolic RNA induced anti-viral signaling by promoting TBK1 K48 ubiquitination. Nat Commun. 2020;11:2193 pubmed publisher
  122. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  123. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  124. Gao M, Wang T, Ji L, Bai S, Tian L, Song H. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer. Front Immunol. 2020;11:366 pubmed publisher
  125. Ramstead A, Wallace J, Lee S, Bauer K, Tang W, Ekiz H, et al. Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis through Metabolic Regulation of Thymic Development. Cell Rep. 2020;30:2889-2899.e6 pubmed publisher
  126. Wei J, Mattapallil M, Horai R, Jittayasothorn Y, Modi A, Sen H, et al. A novel role for lipoxin A4 in driving a lymph node-eye axis that controls autoimmunity to the neuroretina. elife. 2020;9: pubmed publisher
  127. Hu X, Deng Q, Ma L, Li Q, Chen Y, Liao Y, et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 2020;30:229-243 pubmed publisher
  128. Lu H, Kim S, Steelman A, Tracy K, Zhou B, Michaud D, et al. STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination. Proc Natl Acad Sci U S A. 2020;117:5430-5441 pubmed publisher
  129. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  130. Chen C, Chencheng Z, Cuiying L, Xiaokun G. Plasmacytoid Dendritic Cells Protect Against Middle Cerebral Artery Occlusion Induced Brain Injury by Priming Regulatory T Cells. Front Cell Neurosci. 2020;14:8 pubmed publisher
  131. Aslan K, Turco V, Blobner J, Sonner J, Liuzzi A, Núñez N, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931 pubmed publisher
  132. Tizian C, Lahmann A, Hölsken O, Cosovanu C, Kofoed Branzk M, Heinrich F, et al. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells. elife. 2020;9: pubmed publisher
  133. Tzeng S, Patel K, Wilson D, Meyer R, Rhodes K, Green J. In situ genetic engineering of tumors for long-lasting and systemic immunotherapy. Proc Natl Acad Sci U S A. 2020;117:4043-4052 pubmed publisher
  134. Cohen G, Chandran P, Lorsung R, Tomlinson L, Sundby M, Burks S, et al. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel). 2020;12: pubmed publisher
  135. Park M, Kim H, Lee H, Zabel B, Bae Y. Novel CD11b+Gr-1+Sca-1+ myeloid cells drive mortality in bacterial infection. Sci Adv. 2020;6:eaax8820 pubmed publisher
  136. Williams G, Marmion D, Schonhoff A, Jurkuvenaite A, Won W, Standaert D, et al. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathol. 2020;139:855-874 pubmed publisher
  137. Liu Z, Wen J, Wu C, Hu C, Wang J, Bao Q, et al. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma. Aging (Albany NY). 2020;12:1213-1236 pubmed publisher
  138. Zhang B, Ma S, Rachmin I, He M, Baral P, Choi S, et al. Hyperactivation of sympathetic nerves drives depletion of melanocyte stem cells. Nature. 2020;577:676-681 pubmed publisher
  139. Kimura S, Nakamura Y, Kobayashi N, Shiroguchi K, Kawakami E, Mutoh M, et al. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity. Nat Commun. 2020;11:234 pubmed publisher
  140. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  141. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  142. Ward L, Lee D, Sharma A, Wang A, Naouar I, Ma X, et al. Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury. JCI Insight. 2020;5: pubmed publisher
  143. Hang S, Paik D, Yao L, Kim E, Jamma T, Lu J, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143-148 pubmed publisher
  144. Vagnozzi R, Maillet M, Sargent M, Khalil H, Johansen A, Schwanekamp J, et al. An acute immune response underlies the benefit of cardiac stem cell therapy. Nature. 2020;577:405-409 pubmed publisher
  145. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  146. Nagai J, Balestrieri B, Fanning L, Kyin T, Cirka H, Lin J, et al. P2Y6 signaling in alveolar macrophages prevents leukotriene-dependent type 2 allergic lung inflammation. J Clin Invest. 2019;129:5169-5186 pubmed publisher
  147. Yadava K, Medina C, Ishak H, Gurevich I, Kuipers H, Shamskhou E, et al. Natural Tr1-like cells do not confer long-term tolerogenic memory. elife. 2019;8: pubmed publisher
  148. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
  149. Yoshimi A, Lin K, Wiseman D, Rahman M, Pastore A, Wang B, et al. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. Nature. 2019;574:273-277 pubmed publisher
  150. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  151. Chen M, Reed R, Lane A. Chronic Inflammation Directs an Olfactory Stem Cell Functional Switch from Neuroregeneration to Immune Defense. Cell Stem Cell. 2019;25:501-513.e5 pubmed publisher
  152. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  153. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  154. Clancy Thompson E, Chen G, LaMarche N, Ali L, Jeong H, Crowley S, et al. Transnuclear mice reveal Peyer's patch iNKT cells that regulate B-cell class switching to IgG1. EMBO J. 2019;38:e101260 pubmed publisher
  155. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  156. Lee Y, Riopel M, Cabrales P, Bandyopadhyay G. Hepatocyte-specific HIF-1α ablation improves obesity-induced glucose intolerance by reducing first-pass GLP-1 degradation. Sci Adv. 2019;5:eaaw4176 pubmed publisher
  157. Dulken B, Buckley M, Navarro Negredo P, Saligrama N, Cayrol R, Leeman D, et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature. 2019;571:205-210 pubmed publisher
  158. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed publisher
  159. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  160. Kobayakawa K, Ohkawa Y, Yoshizaki S, Tamaru T, Saito T, Kijima K, et al. Macrophage centripetal migration drives spontaneous healing process after spinal cord injury. Sci Adv. 2019;5:eaav5086 pubmed publisher
  161. Komuczki J, Tuzlak S, Friebel E, Hartwig T, Spath S, Rosenstiel P, et al. Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β. Immunity. 2019;: pubmed publisher
  162. Knox T, Sahakian E, Banik D, Hadley M, Palmer E, Noonepalle S, et al. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep. 2019;9:6136 pubmed publisher
  163. Walens A, DiMarco A, Lupo R, Kroger B, Damrauer J, Alvarez J. CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors. elife. 2019;8: pubmed publisher
  164. Esterházy D, Canesso M, Mesin L, Muller P, de Castro T, Lockhart A, et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature. 2019;569:126-130 pubmed publisher
  165. Jacome Galarza C, Percin G, Muller J, Mass E, Lazarov T, Eitler J, et al. Developmental origin, functional maintenance and genetic rescue of osteoclasts. Nature. 2019;568:541-545 pubmed publisher
  166. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  167. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  168. Bottermann M, Foss S, Caddy S, Clift D, van Tienen L, Vaysburd M, et al. Complement C4 Prevents Viral Infection through Capsid Inactivation. Cell Host Microbe. 2019;25:617-629.e7 pubmed publisher
  169. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  170. Kumar P, Rajasekaran K, Nanbakhsh A, Gorski J, Thakar M, Malarkannan S. IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection. Sci Rep. 2019;9:4984 pubmed publisher
  171. Cao Y, Trillo Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression. Nat Commun. 2019;10:1280 pubmed publisher
  172. Melo Gonzalez F, Kammoun H, Evren E, Dutton E, Papadopoulou M, Bradford B, et al. Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria. J Exp Med. 2019;216:728-742 pubmed publisher
  173. Thompson P, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metab. 2019;29:1045-1060.e10 pubmed publisher
  174. Anandagoda N, Willis J, Hertweck A, Roberts L, Jackson I, Gökmen M, et al. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance. J Clin Invest. 2019;129:1257-1271 pubmed publisher
  175. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  176. Davies A, Kim H, González Cano R, Choi J, Back S, Roh S, et al. Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury. Cell. 2019;176:716-728.e18 pubmed publisher
  177. Wheeler M, Jaronen M, Covacu R, Zandee S, Scalisi G, Rothhammer V, et al. Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation. Cell. 2019;176:581-596.e18 pubmed publisher
  178. Lee Y, Ju J, Shon W, Oh S, Min C, Kang M, et al. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD. Immune Netw. 2018;18:e44 pubmed publisher
  179. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  180. Hu K, Huang Q, Liu C, Li Y, Liu Y, Wang H, et al. c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease. Neuroscience. 2019;399:117-124 pubmed publisher
  181. Percin G, Eitler J, Kranz A, Fu J, Pollard J, Naumann R, et al. CSF1R regulates the dendritic cell pool size in adult mice via embryo-derived tissue-resident macrophages. Nat Commun. 2018;9:5279 pubmed publisher
  182. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  183. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  184. Nayar S, Campos J, Smith C, Iannizzotto V, Gardner D, Colafrancesco S, et al. Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome. Ann Rheum Dis. 2019;78:249-260 pubmed publisher
  185. Sharma D, Malik A, Guy C, Vogel P, Kanneganti T. TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy. J Clin Invest. 2019;129:150-162 pubmed publisher
  186. Glal D, Sudhakar J, Lu H, Liu M, Chiang H, Liu Y, et al. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol. 2018;9:2522 pubmed publisher
  187. Wilgenburg B, Loh L, Chen Z, Pediongco T, Wang H, Shi M, et al. MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun. 2018;9:4706 pubmed publisher
  188. Jensen I, Winborn C, Fosdick M, Shao P, Tremblay M, Shan Q, et al. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog. 2018;14:e1007405 pubmed publisher
  189. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  190. Sheng C, Yao C, Wang Z, Chen H, Zhao Y, Xu D, et al. Cyclophilin J limits inflammation through the blockage of ubiquitin chain sensing. Nat Commun. 2018;9:4381 pubmed publisher
  191. Er J, Koean R, Ding J. Loss of T-bet confers survival advantage to influenza-bacterial superinfection. EMBO J. 2019;38: pubmed publisher
  192. Xu X, Xu J, Wu J, Hu Y, Han Y, Gu Y, et al. Phosphorylation-Mediated IFN-γR2 Membrane Translocation Is Required to Activate Macrophage Innate Response. Cell. 2018;175:1336-1351.e17 pubmed publisher
  193. Abreu Mota T, Hagen K, Cooper K, Jahrling P, Tan G, Wirblich C, et al. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Nat Commun. 2018;9:4223 pubmed publisher
  194. Delgado Benito V, Rosen D, Wang Q, Gazumyan A, Pai J, Oliveira T, et al. The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination. Mol Cell. 2018;72:636-649.e8 pubmed publisher
  195. Brun P, Scarpa M, Marchiori C, Conti J, Kotsafti A, Porzionato A, et al. Herpes Simplex Virus Type 1 Engages Toll Like Receptor 2 to Recruit Macrophages During Infection of Enteric Neurons. Front Microbiol. 2018;9:2148 pubmed publisher
  196. Stephens J, Bailey J, Hang H, Rittell V, Dietrich M, Mynatt R, et al. Adipose Tissue Dysfunction Occurs Independently of Obesity in Adipocyte-Specific Oncostatin Receptor Knockout Mice. Obesity (Silver Spring). 2018;26:1439-1447 pubmed publisher
  197. Chen J, Cai Z, Bai M, Yu X, Zhang C, Cao C, et al. The RNA-binding protein ROD1/PTBP3 cotranscriptionally defines AID-loading sites to mediate antibody class switch in mammalian genomes. Cell Res. 2018;28:981-995 pubmed publisher
  198. Schrand B, Clark E, Levay A, Capote A, Martínez O, Brenneman R, et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun. 2018;9:3348 pubmed publisher
  199. Cheng Y, Zhu X, Wang X, Zhuang Q, Huyan X, Sun X, et al. Trichinella spiralis Infection Mitigates Collagen-Induced Arthritis via Programmed Death 1-Mediated Immunomodulation. Front Immunol. 2018;9:1566 pubmed publisher
  200. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt F, Liniany L, Knight D, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018;49:247-263.e7 pubmed publisher
  201. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  202. Cho S, Lee H, Yu I, Choi Y, Huang H, Hashemifar S, et al. Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun. 2018;9:2757 pubmed publisher
  203. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  204. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  205. Abel A, Tiwari A, Gerbec Z, Siebert J, Yang C, Schloemer N, et al. IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells. Front Immunol. 2018;9:1168 pubmed publisher
  206. Gu C, Borjabad A, Hadas E, Kelschenbach J, Kim B, Chao W, et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathog. 2018;14:e1007061 pubmed publisher
  207. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  208. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed publisher
  209. García Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun. 2018;9:1970 pubmed publisher
  210. Hu X, Majchrzak K, Liu X, Wyatt M, Spooner C, Moisan J, et al. In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. Cancer Res. 2018;78:3888-3898 pubmed publisher
  211. Li C, Psatha N, Wang H, Singh M, Samal H, Zhang W, et al. Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies. Mol Ther Methods Clin Dev. 2018;9:142-152 pubmed publisher
  212. Donaldson G, Ladinsky M, Yu K, Sanders J, Yoo B, Chou W, et al. Gut microbiota utilize immunoglobulin A for mucosal colonization. Science. 2018;360:795-800 pubmed publisher
  213. Kling J, Jordan M, Pitt L, Meiners J, Thanh Tran T, Tran L, et al. Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt Signaling. Front Immunol. 2018;9:483 pubmed publisher
  214. Vogl T, Stratis A, Wixler V, Voller T, Thurainayagam S, Jorch S, et al. Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation. J Clin Invest. 2018;128:1852-1866 pubmed publisher
  215. Vigolo M, Chambers M, Willen L, Chevalley D, Maskos K, Lammens A, et al. A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors. Nat Commun. 2018;9:1199 pubmed publisher
  216. Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine T, et al. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest. 2018;128:2487-2499 pubmed publisher
  217. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  218. Moriyama S, Brestoff J, Flamar A, Moeller J, Klose C, Rankin L, et al. β2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses. Science. 2018;359:1056-1061 pubmed publisher
  219. Metghalchi S, Vandestienne M, Haddad Y, Esposito B, Dairou J, Tedgui A, et al. Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet. PLoS ONE. 2018;13:e0193737 pubmed publisher
  220. Lee C, Zhang H, Singh S, Koo L, Kabat J, Tsang H, et al. C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation. elife. 2018;7: pubmed publisher
  221. A Verghese D, Demir M, Chun N, Fribourg M, Cravedi P, Llaudó I, et al. T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival. J Immunol. 2018;200:2186-2198 pubmed publisher
  222. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed publisher
  223. Böttcher J, Bonavita E, Chakravarty P, Blees H, Cabeza Cabrerizo M, Sammicheli S, et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell. 2018;172:1022-1037.e14 pubmed publisher
  224. Dejea C, Fathi P, Craig J, Boleij A, Taddese R, Geis A, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359:592-597 pubmed publisher
  225. Chennupati V, Veiga D, Maslowski K, Andina N, Tardivel A, Yu E, et al. Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation. J Clin Invest. 2018;128:1597-1614 pubmed publisher
  226. Solanki A, Yanez D, Ross S, Lau C, Papaioannou E, Li J, et al. Gli3 in fetal thymic epithelial cells promotes thymocyte positive selection and differentiation by repression of Shh. Development. 2018;145: pubmed publisher
  227. Siracusa F, McGrath M, Maschmeyer P, Bardua M, Lehmann K, Heinz G, et al. Nonfollicular reactivation of bone marrow resident memory CD4 T cells in immune clusters of the bone marrow. Proc Natl Acad Sci U S A. 2018;115:1334-1339 pubmed publisher
  228. Vo L, Kinney M, Liu X, Zhang Y, Barragan J, Sousa P, et al. Regulation of embryonic haematopoietic multipotency by EZH1. Nature. 2018;553:506-510 pubmed publisher
  229. Teater M, Domínguez P, Redmond D, Chen Z, Ennishi D, Scott D, et al. AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis. Nat Commun. 2018;9:222 pubmed publisher
  230. Christ A, Günther P, Lauterbach M, Duewell P, Biswas D, Pelka K, et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell. 2018;172:162-175.e14 pubmed publisher
  231. Garaycoechea J, Crossan G, Langevin F, Mulderrig L, Louzada S, Yang F, et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature. 2018;553:171-177 pubmed publisher
  232. Guarnerio J, Mendez L, Asada N, Menon A, Fung J, Berry K, et al. A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche. Nat Commun. 2018;9:66 pubmed publisher
  233. Barrow A, Edeling M, Trifonov V, Luo J, Goyal P, Bohl B, et al. Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. Cell. 2018;172:534-548.e19 pubmed publisher
  234. Burrack A, Malhotra D, Dileepan T, Osum K, Swanson L, Fife B, et al. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol. 2018;200:477-482 pubmed publisher
  235. Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14 pubmed publisher
  236. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  237. Widjaja Adhi M, Palczewski G, Dale K, Knauss E, Kelly M, Golczak M, et al. Transcription factor ISX mediates the cross talk between diet and immunity. Proc Natl Acad Sci U S A. 2017;114:11530-11535 pubmed publisher
  238. Mao A, Ishizuka I, Kasal D, Mandal M, Bendelac A. A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development. Nat Commun. 2017;8:863 pubmed publisher
  239. Bern M, Beckman D, Ebihara T, Taffner S, Poursine Laurent J, White J, et al. Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor. Proc Natl Acad Sci U S A. 2017;114:E8440-E8447 pubmed publisher
  240. Cole C, Russler Germain D, Ketkar S, Verdoni A, Smith A, Bangert C, et al. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies. J Clin Invest. 2017;127:3657-3674 pubmed publisher
  241. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  242. Yi W, Gupta S, Ricker E, Manni M, Jessberger R, Chinenov Y, et al. The mTORC1-4E-BP-eIF4E axis controls de novo Bcl6 protein synthesis in T cells and systemic autoimmunity. Nat Commun. 2017;8:254 pubmed publisher
  243. Funken D, Ishikawa Ankerhold H, Uhl B, Lerchenberger M, Rentsch M, Mayr D, et al. In situ targeting of dendritic cells sets tolerogenic environment and ameliorates CD4+ T-cell response in the postischemic liver. FASEB J. 2017;31:4796-4808 pubmed publisher
  244. Sitrin J, Suto E, Wuster A, Eastham Anderson J, Kim J, Austin C, et al. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice. J Immunol. 2017;199:1238-1249 pubmed publisher
  245. Alloatti A, Rookhuizen D, Joannas L, Carpier J, Iborra S, Magalhaes J, et al. Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity. J Exp Med. 2017;214:2231-2241 pubmed publisher
  246. Hattori A, Tsunoda M, Konuma T, Kobayashi M, Nagy T, Glushka J, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature. 2017;545:500-504 pubmed publisher
  247. Kraakman M, Lee M, Al Sharea A, Dragoljevic D, Barrett T, Montenont E, et al. Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest. 2017;127:2133-2147 pubmed publisher
  248. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  249. Ip W, Hoshi N, Shouval D, Snapper S, Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356:513-519 pubmed publisher
  250. Audzevich T, Bashford Rogers R, Mabbott N, Frampton D, Freeman T, Potocnik A, et al. Pre/pro-B cells generate macrophage populations during homeostasis and inflammation. Proc Natl Acad Sci U S A. 2017;114:E3954-E3963 pubmed publisher
  251. Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, et al. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med. 2017;214:1471-1491 pubmed publisher
  252. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  253. van der Vlugt L, Obieglo K, Ozir Fazalalikhan A, Sparwasser T, Haeberlein S, Smits H. Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function. Int J Parasitol. 2017;47:545-554 pubmed publisher
  254. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  255. Tian L, Goldstein A, Wang H, Ching Lo H, Sun Kim I, Welte T, et al. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017;544:250-254 pubmed publisher
  256. Martinez Jimenez C, Eling N, Chen H, Vallejos C, Kolodziejczyk A, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science. 2017;355:1433-1436 pubmed publisher
  257. Hérault A, Binnewies M, Leong S, Calero Nieto F, Zhang S, Kang Y, et al. Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis. Nature. 2017;544:53-58 pubmed publisher
  258. He W, Wang C, Mu R, Liang P, Huang Z, Zhang J, et al. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene. 2017;36:4212-4223 pubmed publisher
  259. Lefrançais E, Ortiz Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah D, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544:105-109 pubmed publisher
  260. Tewes S, Gueler F, Chen R, Gutberlet M, Jang M, Meier M, et al. Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains. PLoS ONE. 2017;12:e0173248 pubmed publisher
  261. Barthels C, Ogrinc A, Steyer V, Meier S, Simon F, Wimmer M, et al. CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis. Nat Commun. 2017;8:14715 pubmed publisher
  262. Wagner J, Jaurich H, Wallner C, Abraham S, Becerikli M, Dadras M, et al. Diminished bone regeneration after debridement of posttraumatic osteomyelitis is accompanied by altered cytokine levels, elevated B cell activity, and increased osteoclast activity. J Orthop Res. 2017;35:2425-2434 pubmed publisher
  263. Guidi N, Sacma M, Ständker L, Soller K, Marka G, Eiwen K, et al. Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells. EMBO J. 2017;36:840-853 pubmed publisher
  264. Baranek T, Morello E, Valayer A, Aimar R, Bréa D, Henry C, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol. 2017;8:123 pubmed publisher
  265. Ho T, Warr M, Adelman E, Lansinger O, Flach J, Verovskaya E, et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature. 2017;543:205-210 pubmed publisher
  266. Wang H, Mo L, Xiao X, An S, Liu X, Ba J, et al. Pplase of Dermatophagoides farinae promotes ovalbumin-induced airway allergy by modulating the functions of dendritic cells in a mouse model. Sci Rep. 2017;7:43322 pubmed publisher
  267. Stanley R, Piszczatowski R, Bartholdy B, Mitchell K, McKimpson W, Narayanagari S, et al. A myeloid tumor suppressor role for NOL3. J Exp Med. 2017;214:753-771 pubmed publisher
  268. Sanges S, Jendoubi M, Kavian N, Hauspie C, Speca S, Crave J, et al. B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis. Front Immunol. 2017;8:53 pubmed publisher
  269. Huang A, Peng D, Guo H, Ben Y, Zuo X, Wu F, et al. A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies. Sci Rep. 2017;7:42687 pubmed publisher
  270. Zamarin D, Holmgaard R, Ricca J, Plitt T, Palese P, Sharma P, et al. Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nat Commun. 2017;8:14340 pubmed publisher
  271. Vaitaitis G, Yussman M, Waid D, Wagner D. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells. PLoS ONE. 2017;12:e0172037 pubmed publisher
  272. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  273. Mylvaganam G, Rios D, Abdelaal H, Iyer S, Tharp G, Mavigner M, et al. Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection. Proc Natl Acad Sci U S A. 2017;114:1976-1981 pubmed publisher
  274. Berlato C, Khan M, Schioppa T, Thompson R, Maniati E, Montfort A, et al. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest. 2017;127:801-813 pubmed publisher
  275. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  276. Edwards R, Kopp S, Ifergan I, Shui J, Kronenberg M, Miller S, et al. Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy. Invest Ophthalmol Vis Sci. 2017;58:282-291 pubmed publisher
  277. Hattori A, McSkimming D, Kannan N, Ito T. RNA binding protein MSI2 positively regulates FLT3 expression in myeloid leukemia. Leuk Res. 2017;54:47-54 pubmed publisher
  278. Goverse G, Molenaar R, Macia L, Tan J, Erkelens M, Konijn T, et al. Diet-Derived Short Chain Fatty Acids Stimulate Intestinal Epithelial Cells To Induce Mucosal Tolerogenic Dendritic Cells. J Immunol. 2017;198:2172-2181 pubmed publisher
  279. Dror E, Dalmas E, Meier D, Wueest S, Thévenet J, Thienel C, et al. Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol. 2017;18:283-292 pubmed publisher
  280. Zhu J, Cifuentes H, Reynolds J, Lamba D. Immunosuppression via Loss of IL2rγ Enhances Long-Term Functional Integration of hESC-Derived Photoreceptors in the Mouse Retina. Cell Stem Cell. 2017;20:374-384.e5 pubmed publisher
  281. Blanquiceth Y, Rodríguez Perea A, Tabares Guevara J, Correa L, Sánchez M, Ramirez Pineda J, et al. Increase of Frequency and Modulation of Phenotype of Regulatory T Cells by Atorvastatin Is Associated with Decreased Lung Inflammatory Cell Infiltration in a Murine Model of Acute Allergic Asthma. Front Immunol. 2016;7:620 pubmed publisher
  282. Araujo L, Khim P, Mkhikian H, Mortales C, Demetriou M. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. elife. 2017;6: pubmed publisher
  283. Atkin Smith G, Paone S, Zanker D, Duan M, Phan T, Chen W, et al. Isolation of cell type-specific apoptotic bodies by fluorescence-activated cell sorting. Sci Rep. 2017;7:39846 pubmed publisher
  284. Larabee C, Desai S, Agasing A, Georgescu C, Wren J, Axtell R, et al. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Mol Vis. 2016;22:1503-1513 pubmed
  285. Chen S, Cai C, Li Z, Liu G, Wang Y, Blonska M, et al. Dissection of SAP-dependent and SAP-independent SLAM family signaling in NKT cell development and humoral immunity. J Exp Med. 2017;214:475-489 pubmed publisher
  286. Weindel C, Richey L, Mehta A, Shah M, Huber B. Autophagy in Dendritic Cells and B Cells Is Critical for the Inflammatory State of TLR7-Mediated Autoimmunity. J Immunol. 2017;198:1081-1092 pubmed publisher
  287. Xu X, Han L, Zhao G, Xue S, Gao Y, Xiao J, et al. LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis. J Exp Med. 2017;214:209-226 pubmed publisher
  288. Aguilera T, Rafat M, Castellini L, Shehade H, Kariolis M, Hui A, et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat Commun. 2016;7:13898 pubmed publisher
  289. Zhang Y, Yu J, Grachtchouk V, Qin T, Lumeng C, Sartor M, et al. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer. Oncotarget. 2017;8:5761-5773 pubmed publisher
  290. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed publisher
  291. Yang J, Tanaka Y, Seay M, Li Z, Jin J, Garmire L, et al. Single cell transcriptomics reveals unanticipated features of early hematopoietic precursors. Nucleic Acids Res. 2017;45:1281-1296 pubmed publisher
  292. Gadani S, Smirnov I, Smith A, Overall C, Kipnis J. Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury. J Exp Med. 2017;214:285-296 pubmed publisher
  293. Nair V, Song M, Ko M, Oh K. DNA Demethylation of the Foxp3 Enhancer Is Maintained through Modulation of Ten-Eleven-Translocation and DNA Methyltransferases. Mol Cells. 2016;39:888-897 pubmed publisher
  294. Karki R, Man S, Malireddi R, Kesavardhana S, Zhu Q, Burton A, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature. 2016;540:583-587 pubmed publisher
  295. Herzig Y, Nevo S, Bornstein C, Brezis M, Ben Hur S, Shkedy A, et al. Transcriptional programs that control expression of the autoimmune regulator gene Aire. Nat Immunol. 2017;18:161-172 pubmed publisher
  296. Bieber K, Witte M, Sun S, Hundt J, Kalies K, Dräger S, et al. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Sci Rep. 2016;6:38357 pubmed publisher
  297. Yanagisawa H, Hashimoto M, Minagawa S, Takasaka N, Ma R, Moermans C, et al. Role of IL-17A in murine models of COPD airway disease. Am J Physiol Lung Cell Mol Physiol. 2017;312:L122-L130 pubmed publisher
  298. Moroishi T, Hayashi T, Pan W, Fujita Y, Holt M, Qin J, et al. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016;167:1525-1539.e17 pubmed publisher
  299. Weyandt J, Carney J, Pavlisko E, Xu M, Counter C. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice. PLoS ONE. 2016;11:e0167205 pubmed publisher
  300. Le Q, Yao W, Chen Y, Yan B, Liu C, Yuan M, et al. GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal. Cell Death Dis. 2016;7:e2478 pubmed publisher
  301. Yu V, Yusuf R, Oki T, Wu J, Saez B, Wang X, et al. Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells. Cell. 2016;167:1310-1322.e17 pubmed publisher
  302. Meng C, Li Z, Fang W, Song Z, Yang D, Li D, et al. Cytochrome P450 26A1 modulates natural killer cells in mouse early pregnancy. J Cell Mol Med. 2017;21:697-710 pubmed publisher
  303. Cummings R, Barbet G, Bongers G, Hartmann B, Gettler K, Muniz L, et al. Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs. Nature. 2016;539:565-569 pubmed publisher
  304. Shirakawa K, Yan X, Shinmura K, Endo J, Kataoka M, Katsumata Y, et al. Obesity accelerates T cell senescence in murine visceral adipose tissue. J Clin Invest. 2016;126:4626-4639 pubmed publisher
  305. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  306. Carroll V, Lafferty M, Marchionni L, Bryant J, Gallo R, Garzino Demo A. Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice. Proc Natl Acad Sci U S A. 2016;113:13168-13173 pubmed
  307. Dong L, Yu W, Zheng H, Loh M, Bunting S, Pauly M, et al. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. Nature. 2016;539:304-308 pubmed publisher
  308. Michailidou I, Naessens D, Hametner S, Guldenaar W, Kooi E, Geurts J, et al. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. 2017;65:264-277 pubmed publisher
  309. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  310. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed publisher
  311. Holzlechner M, Strasser K, Zareva E, Steinhäuser L, Birnleitner H, Beer A, et al. In Situ Characterization of Tissue-Resident Immune Cells by MALDI Mass Spectrometry Imaging. J Proteome Res. 2017;16:65-76 pubmed publisher
  312. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  313. Georgiev H, Ravens I, Benarafa C, Forster R, Bernhardt G. Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets. Nat Commun. 2016;7:13116 pubmed publisher
  314. Lopez Guadamillas E, Fernandez Marcos P, Pantoja C, Muñoz Martin M, Martinez D, Gomez Lopez G, et al. p21Cip1 plays a critical role in the physiological adaptation to fasting through activation of PPAR?. Sci Rep. 2016;6:34542 pubmed publisher
  315. Ramirez Carrozzi V, Sambandam A, Zhou M, Yan D, Kang J, Wu X, et al. Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of type 2 inflammation over inhibition of either pathway alone. J Allergy Clin Immunol. 2017;139:705-708.e6 pubmed publisher
  316. Ippagunta S, Gangwar R, Finkelstein D, Vogel P, Pelletier S, Gingras S, et al. Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function. Proc Natl Acad Sci U S A. 2016;113:E6162-E6171 pubmed
  317. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  318. Milanovic M, Heise N, De Silva N, Anderson M, Silva K, Carette A, et al. Differential requirements for the canonical NF-?B transcription factors c-REL and RELA during the generation and activation of mature B cells. Immunol Cell Biol. 2017;95:261-271 pubmed publisher
  319. Kaneda M, Messer K, Ralainirina N, Li H, Leem C, Gorjestani S, et al. PI3Kγ is a molecular switch that controls immune suppression. Nature. 2016;539:437-442 pubmed publisher
  320. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  321. Rudemiller N, Patel M, Zhang J, Jeffs A, Karlovich N, Griffiths R, et al. C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration. Am J Pathol. 2016;186:2846-2856 pubmed publisher
  322. Eil R, Vodnala S, Clever D, Klebanoff C, Sukumar M, Pan J, et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature. 2016;537:539-543 pubmed publisher
  323. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel A, et al. Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res. 2017;23:1220-1226 pubmed publisher
  324. Uhde A, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, et al. Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice. PLoS ONE. 2016;11:e0161883 pubmed publisher
  325. Xiong X, Gu L, Wang Y, Luo Y, Zhang H, Lee J, et al. Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms. J Neuroinflammation. 2016;13:241 pubmed publisher
  326. Hoegl S, Ehrentraut H, Brodsky K, Victorino F, Golden Mason L, Eltzschig H, et al. NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury. J Leukoc Biol. 2017;101:471-480 pubmed publisher
  327. Chew W, Tabebordbar M, Cheng J, Mali P, Wu E, Ng A, et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat Methods. 2016;13:868-74 pubmed publisher
  328. Xia G, Wu S, Zhang Y. Anti-4-1BB monoclonal antibodies attenuate concanavalin A-induced immune-mediated liver injury in mice. Exp Ther Med. 2016;12:1263-1268 pubmed
  329. Ushiki T, Huntington N, Glaser S, Kiu H, Georgiou A, Zhang J, et al. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells. PLoS ONE. 2016;11:e0162111 pubmed publisher
  330. Jackson Jones L, Duncan S, Magalhaes M, Campbell S, Maizels R, McSorley H, et al. Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation. Nat Commun. 2016;7:12651 pubmed publisher
  331. Zhang S, Liu X, Mei L, Wang H, Fang F. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice. BMC Complement Altern Med. 2016;16:334 pubmed publisher
  332. Kong S, Yang Y, Xu Y, Wang Y, Zhang Y, Melo Cardenas J, et al. Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas. Proc Natl Acad Sci U S A. 2016;113:10394-9 pubmed publisher
  333. Guo H, Cranert S, Lu Y, Zhong M, Zhang S, Chen J, et al. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. J Exp Med. 2016;213:2187-207 pubmed publisher
  334. Inoue T, Griffin D, Huq R, Samuel E, Ruano S, Stinnett G, et al. Characterization of a novel MR-detectable nanoantioxidant that mitigates the recall immune response. NMR Biomed. 2016;29:1436-44 pubmed publisher
  335. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  336. Yoon J, Leyva Castillo J, Wang G, Galand C, Oyoshi M, Kumar L, et al. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med. 2016;213:2147-66 pubmed publisher
  337. He C, Duan X, Guo N, Chan C, Poon C, Weichselbaum R, et al. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun. 2016;7:12499 pubmed publisher
  338. Henry E, Sy C, Inclan Rico J, Espinosa V, Ghanny S, Dwyer D, et al. Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med. 2016;213:1663-73 pubmed publisher
  339. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed publisher
  340. Belinson H, Savage A, Fadrosh D, Kuo Y, Lin D, Valladares R, et al. Dual epithelial and immune cell function of Dvl1 regulates gut microbiota composition and intestinal homeostasis. JCI Insight. 2016;1: pubmed publisher
  341. You L, Li L, Zou J, Yan K, Belle J, Nijnik A, et al. BRPF1 is essential for development of fetal hematopoietic stem cells. J Clin Invest. 2016;126:3247-62 pubmed publisher
  342. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  343. Chen S, Miyazaki M, Chandra V, Fisch K, Chang A, Murre C. Id3 Orchestrates Germinal Center B Cell Development. Mol Cell Biol. 2016;36:2543-52 pubmed publisher
  344. Lesina M, Wörmann S, Morton J, Diakopoulos K, Korneeva O, Wimmer M, et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest. 2016;126:2919-32 pubmed publisher
  345. Schweiger T, Berghoff A, Glogner C, Glueck O, Rajky O, Traxler D, et al. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Clin Exp Metastasis. 2016;33:727-39 pubmed publisher
  346. Weiss J, Chen W, Nyuydzefe M, Trzeciak A, Flynn R, Tonra J, et al. ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings. Sci Signal. 2016;9:ra73 pubmed publisher
  347. Wang S, Xia P, Chen Y, Huang G, Xiong Z, Liu J, et al. Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection. Immunity. 2016;45:131-44 pubmed publisher
  348. Xu Y, Zhao F, Qiu Q, Chen K, Wei J, Kong Q, et al. The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity. Nat Commun. 2016;7:12073 pubmed publisher
  349. Hoppe P, Schwarzfischer M, Loeffler D, Kokkaliaris K, Hilsenbeck O, Moritz N, et al. Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios. Nature. 2016;535:299-302 pubmed publisher
  350. Ibiza S, García Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature. 2016;535:440-443 pubmed publisher
  351. Stifter K, Schuster C, Schlosser M, Boehm B, Schirmbeck R. Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination. Sci Rep. 2016;6:29419 pubmed publisher
  352. Konkalmatt P, Asico L, Zhang Y, Yang Y, Drachenberg C, Zheng X, et al. Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight. 2016;1: pubmed
  353. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  354. Kathania M, Khare P, Zeng M, Cantarel B, Zhang H, Ueno H, et al. Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-?t ubiquitination. Nat Immunol. 2016;17:997-1004 pubmed publisher
  355. Terashima A, Okamoto K, Nakashima T, Akira S, Ikuta K, Takayanagi H. Sepsis-Induced Osteoblast Ablation Causes Immunodeficiency. Immunity. 2016;44:1434-43 pubmed publisher
  356. Stentzel S, Teufelberger A, Nordengrün M, Kolata J, Schmidt F, Van Crombruggen K, et al. Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus. J Allergy Clin Immunol. 2017;139:492-500.e8 pubmed publisher
  357. Ruhland M, Loza A, Capietto A, Luo X, Knolhoff B, Flanagan K, et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun. 2016;7:11762 pubmed publisher
  358. Salvi V, Vermi W, Gianello V, Lonardi S, Gagliostro V, Naldini A, et al. Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors. Oncotarget. 2016;7:39256-39269 pubmed publisher
  359. Abramowski P, Krasemann S, Ernst T, Lange C, Ittrich H, Schweizer M, et al. Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice. Stem Cells Dev. 2016;25:1134-48 pubmed publisher
  360. Seehus C, Kaye J. In vitro Differentiation of Murine Innate Lymphoid Cells from Common Lymphoid Progenitor Cells. Bio Protoc. 2016;6: pubmed
  361. Stein S, Mack E, Rome K, Pajcini K, Ohtani T, Xu L, et al. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL. PLoS ONE. 2016;11:e0155408 pubmed publisher
  362. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  363. Brandstätter O, Schanz O, Vorac J, König J, Mori T, Maruyama T, et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep. 2016;6:26091 pubmed publisher
  364. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  365. Szalay G, Martinecz B, Lénárt N, Kornyei Z, Orsolits B, Judák L, et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499 pubmed publisher
  366. Yao Y, Norris E, Mason C, Strickland S. Laminin regulates PDGFR?(+) cell stemness and muscle development. Nat Commun. 2016;7:11415 pubmed publisher
  367. Rialdi A, Campisi L, Zhao N, Lagda A, Pietzsch C, Ho J, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 2016;352:aad7993 pubmed publisher
  368. Pietras E, Mirantes Barbeito C, Fong S, Loeffler D, Kovtonyuk L, Zhang S, et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016;18:607-18 pubmed publisher
  369. Swamy M, Pathak S, Grzes K, Damerow S, Sinclair L, van Aalten D, et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat Immunol. 2016;17:712-20 pubmed publisher
  370. Song Z, Li Z, Li D, Fang W, Liu H, Yang D, et al. Seminal plasma induces inflammation in the uterus through the ?? T/IL-17 pathway. Sci Rep. 2016;6:25118 pubmed publisher
  371. Riabov V, Yin S, Song B, Avdic A, Schledzewski K, Ovsiy I, et al. Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. Oncotarget. 2016;7:31097-110 pubmed publisher
  372. Li Z, Hodgkinson T, Gothard E, Boroumand S, Lamb R, Cummins I, et al. Epidermal Notch1 recruits RORγ(+) group 3 innate lymphoid cells to orchestrate normal skin repair. Nat Commun. 2016;7:11394 pubmed publisher
  373. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed publisher
  374. Haemmerle M, Bottsford Miller J, Pradeep S, Taylor M, Choi H, Hansen J, et al. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. J Clin Invest. 2016;126:1885-96 pubmed publisher
  375. Vandenberk L, Garg A, Verschuere T, Koks C, Belmans J, Beullens M, et al. Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. Oncoimmunology. 2016;5:e1083669 pubmed
  376. Oudhoff M, Braam M, Freeman S, Wong D, Rattray D, Wang J, et al. SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/?-Catenin and Hippo/YAP Signaling. Dev Cell. 2016;37:47-57 pubmed publisher
  377. Griffiths K, Dolezal O, Cao B, Nilsson S, See H, Pfleger K, et al. i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4. J Biol Chem. 2016;291:12641-57 pubmed publisher
  378. Yang Y, Xu J, Chen H, Fei X, Tang Y, Yan Y, et al. MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells. Oncotarget. 2016;7:17520-31 pubmed publisher
  379. Martin B, Wang C, Zhang C, Kang Z, Gulen M, Zepp J, et al. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis. Nat Immunol. 2016;17:583-92 pubmed publisher
  380. Gossmann J, Stolte M, Lohoff M, Yu P, Moll R, Finkernagel F, et al. A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma. PLoS ONE. 2016;11:e0150411 pubmed publisher
  381. Marek I, Lichtneger T, Cordasic N, Hilgers K, Volkert G, Fahlbusch F, et al. Alpha8 Integrin (Itga8) Signalling Attenuates Chronic Renal Interstitial Fibrosis by Reducing Fibroblast Activation, Not by Interfering with Regulation of Cell Turnover. PLoS ONE. 2016;11:e0150471 pubmed publisher
  382. Frodermann V, Van Duijn J, van Puijvelde G, van Santbrink P, Lagraauw H, de Vries M, et al. Heat-killed Staphylococcus aureus reduces atherosclerosis by inducing anti-inflammatory macrophages. J Intern Med. 2016;279:592-605 pubmed publisher
  383. Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Rea D, Barbieri A, et al. A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice. J Transl Med. 2016;14:58 pubmed publisher
  384. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  385. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  386. Singhal G, Fisher F, Chee M, Tan T, El Ouaamari A, Adams A, et al. Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas. PLoS ONE. 2016;11:e0148252 pubmed publisher
  387. Chen J, Miyanishi M, Wang S, Yamazaki S, Sinha R, Kao K, et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche. Nature. 2016;530:223-7 pubmed publisher
  388. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  389. Gibson Corley K, Boyden A, Leidinger M, Lambertz A, Ofori Amanfo G, Naumann P, et al. A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis. Peerj. 2016;4:e1600 pubmed publisher
  390. Haque M, Song J, Fino K, Sandhu P, Song X, Lei F, et al. Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity. Sci Rep. 2016;6:20588 pubmed publisher
  391. Gillespie A, Teoh J, Lee H, Prince J, Stadnisky M, Anderson M, et al. Genomic Modifiers of Natural Killer Cells, Immune Responsiveness and Lymphoid Tissue Remodeling Together Increase Host Resistance to Viral Infection. PLoS Pathog. 2016;12:e1005419 pubmed publisher
  392. Azpilikueta A, Agorreta J, Labiano S, Pérez Gracia J, Sánchez Paulete A, Aznar M, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016;11:524-36 pubmed publisher
  393. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  394. Tubo N, Fife B, Pagán A, Kotov D, Goldberg M, Jenkins M. Most microbe-specific naïve CD4? T cells produce memory cells during infection. Science. 2016;351:511-4 pubmed publisher
  395. Caballero Franco C, Guma M, Choo M, Sano Y, Enzler T, Karin M, et al. Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38?-Dependent Restraint of NF-?B Signaling. J Immunol. 2016;196:2368-76 pubmed publisher
  396. Luchsinger L, de Almeida M, Corrigan D, Mumau M, Snoeck H. Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential. Nature. 2016;529:528-31 pubmed publisher
  397. Kuipers H, Rieck M, Gurevich I, Nagy N, Butte M, Negrin R, et al. Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc Natl Acad Sci U S A. 2016;113:1339-44 pubmed publisher
  398. Wang L, Jiang Y, Song X, Guo C, Zhu F, Wang X, et al. Pdcd4 deficiency enhances macrophage lipoautophagy and attenuates foam cell formation and atherosclerosis in mice. Cell Death Dis. 2016;7:e2055 pubmed publisher
  399. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  400. Lu K, Tounsi A, Shridhar N, Küblbeck G, Klevenz A, Prokosch S, et al. Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells. Front Immunol. 2015;6:645 pubmed publisher
  401. Whibley N, Tritto E, Traggiai E, Kolbinger F, Moulin P, Brees D, et al. Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis. J Leukoc Biol. 2016;99:1153-64 pubmed publisher
  402. Zhang T, Zhang Y, Cui M, Jin L, Wang Y, Lv F, et al. CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med. 2016;22:175-82 pubmed publisher
  403. Gallego Ortega D, Ledger A, Roden D, Law A, Magenau A, Kikhtyak Z, et al. ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells. PLoS Biol. 2015;13:e1002330 pubmed publisher
  404. Zahavi T, Lanton T, Divon M, Salmon A, Peretz T, Galun E, et al. Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model. Oncotarget. 2016;7:4860-70 pubmed publisher
  405. Egan C, Sodhi C, Good M, Lin J, Jia H, Yamaguchi Y, et al. Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. J Clin Invest. 2016;126:495-508 pubmed
  406. von Moltke J, Ji M, Liang H, Locksley R. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature. 2016;529:221-5 pubmed publisher
  407. Ren Y, Wang N, Hu W, Zhang X, Xu J, Wan Y. Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination. Sci Rep. 2015;5:18099 pubmed publisher
  408. Liu T, Weng S, Wang M, Huang W. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS. 2016;124:216-20 pubmed publisher
  409. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  410. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  411. Wei R, Hu Y, Dong F, Xu X, Hu A, Gao G. Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells. Immunol Cell Biol. 2016;94:388-99 pubmed publisher
  412. Höftberger R, Leisser M, Bauer J, Lassmann H. Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?. Acta Neuropathol Commun. 2015;3:80 pubmed publisher
  413. Liu Q, Yang R, Huang X, Zhang H, He L, Zhang L, et al. Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes. Cell Res. 2016;26:119-30 pubmed publisher
  414. Kaplan J, Marshall M, C McSkimming C, Harmon D, Garmey J, Oldham S, et al. Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue. Mol Metab. 2015;4:779-94 pubmed publisher
  415. Schachtner H, Weimershaus M, Stache V, Plewa N, Legler D, Höpken U, et al. Loss of Gadkin Affects Dendritic Cell Migration In Vitro. PLoS ONE. 2015;10:e0143883 pubmed publisher
  416. Zhong C, Cui K, Wilhelm C, Hu G, Mao K, Belkaid Y, et al. Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment. Nat Immunol. 2016;17:169-78 pubmed publisher
  417. Cole C, Verdoni A, Ketkar S, Leight E, Russler Germain D, Lamprecht T, et al. PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia. J Clin Invest. 2016;126:85-98 pubmed publisher
  418. Skeldon A, Morizot A, Douglas T, Santoro N, Kursawe R, Kozlitina J, et al. Caspase-12, but Not Caspase-11, Inhibits Obesity and Insulin Resistance. J Immunol. 2016;196:437-47 pubmed publisher
  419. Zhang Z, Wu N, Lu Y, Davidson D, Colonna M, Veillette A. DNAM-1 controls NK cell activation via an ITT-like motif. J Exp Med. 2015;212:2165-82 pubmed publisher
  420. Sekiya T, Yoshimura A. In Vitro Th Differentiation Protocol. Methods Mol Biol. 2016;1344:183-91 pubmed publisher
  421. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed publisher
  422. Li L, Xu L, Yan J, Zhen Z, Ji Y, Liu C, et al. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:129 pubmed publisher
  423. Stachtea X, Tykesson E, van Kuppevelt T, Feinstein R, Malmström A, Reijmers R, et al. Dermatan Sulfate-Free Mice Display Embryological Defects and Are Neonatal Lethal Despite Normal Lymphoid and Non-Lymphoid Organogenesis. PLoS ONE. 2015;10:e0140279 pubmed publisher
  424. Ruan S, Samuelson D, Assouline B, Morre M, Shellito J. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice. Infect Immun. 2016;84:108-19 pubmed publisher
  425. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  426. Varney M, Niederkorn M, Konno H, Matsumura T, Gohda J, Yoshida N, et al. Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling. J Exp Med. 2015;212:1967-85 pubmed publisher
  427. Alvarez S, Diaz M, Flach J, Rodriguez Acebes S, López Contreras A, Martinez D, et al. Replication stress caused by low MCM expression limits fetal erythropoiesis and hematopoietic stem cell functionality. Nat Commun. 2015;6:8548 pubmed publisher
  428. Liu K, Yang K, Wu B, Chen H, Chen X, Chen X, et al. Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore). 2015;94:e1631 pubmed publisher
  429. Zanvit P, Konkel J, Jiao X, Kasagi S, Zhang D, Wu R, et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis. Nat Commun. 2015;6:8424 pubmed publisher
  430. Li S, Dislich B, Brakebusch C, Lichtenthaler S, Brocker T. Control of Homeostasis and Dendritic Cell Survival by the GTPase RhoA. J Immunol. 2015;195:4244-56 pubmed publisher
  431. Yeung H, Lo P, Ng D, Fong W. Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model. Cell Mol Immunol. 2017;14:223-234 pubmed publisher
  432. Masek Hammerman K, Peeva E, Ahmad A, Menon S, Afsharvand M, Peng Qu R, et al. Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupu. Clin Exp Immunol. 2016;183:258-70 pubmed publisher
  433. Shirasuna K, Karasawa T, Usui F, Kobayashi M, Komada T, Kimura H, et al. NLRP3 Deficiency Improves Angiotensin II-Induced Hypertension But Not Fetal Growth Restriction During Pregnancy. Endocrinology. 2015;156:4281-92 pubmed publisher
  434. Loyer X, Paradis V, Hénique C, Vion A, Colnot N, Guerin C, et al. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Gut. 2016;65:1882-1894 pubmed publisher
  435. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  436. Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K, Ishikawa M, et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat Immunol. 2015;16:1077-84 pubmed publisher
  437. Wang X, Huang Z, Chen Y, Lu X, Zhu P, Wen K, et al. A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus. PLoS ONE. 2015;10:e0136888 pubmed publisher
  438. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  439. Matsuda Y, Wang X, Oishi H, Guan Z, Saito M, Liu M, et al. Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation. Am J Transplant. 2016;16:342-52 pubmed publisher
  440. Smith K, Filbey K, Reynolds L, Hewitson J, Harcus Y, Boon L, et al. Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal Immunol. 2016;9:428-43 pubmed publisher
  441. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed publisher
  442. Fujimura N, Xu B, Dalman J, Deng H, Aoyama K, Dalman R. CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow. Sci Rep. 2015;5:11664 pubmed publisher
  443. Vettorazzi S, Bode C, Dejager L, Frappart L, Shelest E, Klaßen C, et al. Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nat Commun. 2015;6:7796 pubmed publisher
  444. Lowe K, Navarro Núñez L, Bénézech C, Nayar S, Kingston B, Nieswandt B, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol. 2015;45:2484-93 pubmed publisher
  445. Patyka M, Malamud D, Weissman D, Abrams W, Kurago Z. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study. PLoS ONE. 2015;10:e0132942 pubmed publisher
  446. Jiang Y, Gao Q, Wang L, Guo C, Zhu F, Wang B, et al. Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice. Cell Mol Immunol. 2016;13:524-34 pubmed publisher
  447. Jasinski Bergner S, Stoehr C, Bukur J, Massa C, Braun J, Hüttelmaier S, et al. Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma. Oncoimmunology. 2015;4:e1008805 pubmed
  448. Saulep Easton D, Vincent F, Quah P, Wei A, Ting S, Croce C, et al. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. 2016;30:163-72 pubmed publisher
  449. Weindel C, Richey L, Bolland S, Mehta A, Kearney J, Huber B. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy. 2015;11:1010-24 pubmed publisher
  450. Charmsaz S, Beckett K, Smith F, Bruedigam C, Moore A, Al Ejeh F, et al. EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia. PLoS ONE. 2015;10:e0130692 pubmed publisher
  451. Horn T, Laus J, Seitz A, Maurer T, Schmid S, Wolf P, et al. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer. World J Urol. 2016;34:181-7 pubmed publisher
  452. Louveau A, Smirnov I, Keyes T, Eccles J, Rouhani S, Peske J, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337-41 pubmed publisher
  453. Hernández P, Mahlakõiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, et al. Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol. 2015;16:698-707 pubmed publisher
  454. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  455. Peske J, Thompson E, Gemta L, Baylis R, Fu Y, Engelhard V. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114 pubmed publisher
  456. Li Y, Kang G, Duan L, Lu W, Katze M, Lewis M, et al. SIV Infection of Lung Macrophages. PLoS ONE. 2015;10:e0125500 pubmed publisher
  457. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  458. Dahlgren M, Gustafsson Hedberg T, Livingston M, Cucak H, Alsén S, Yrlid U, et al. T follicular helper, but not Th1, cell differentiation in the absence of conventional dendritic cells. J Immunol. 2015;194:5187-99 pubmed publisher
  459. Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun. 2015;6:6970 pubmed publisher
  460. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  461. Rogers R, Eastham Anderson J, DeVoss J, Lesch J, Yan D, Xu M, et al. Image Analysis-Based Approaches for Scoring Mouse Models of Colitis. Vet Pathol. 2016;53:200-10 pubmed publisher
  462. Maiwald S, Motazacker M, van Capelleveen J, Sivapalaratnam S, van der Wal A, van der Loos C, et al. A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis. Eur J Hum Genet. 2016;24:86-91 pubmed publisher
  463. Heinzmann D, Bangert A, Müller A, von Ungern Sternberg S, Emschermann F, Schönberger T, et al. The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis. PLoS ONE. 2015;10:e0124606 pubmed publisher
  464. Siegemund S, Shepherd J, Xiao C, Sauer K. hCD2-iCre and Vav-iCre mediated gene recombination patterns in murine hematopoietic cells. PLoS ONE. 2015;10:e0124661 pubmed publisher
  465. Kim P, Nakano H, Das P, Chen M, Rowe R, Chou S, et al. Flow-induced protein kinase A-CREB pathway acts via BMP signaling to promote HSC emergence. J Exp Med. 2015;212:633-48 pubmed publisher
  466. Wan W, Liu Q, Lionakis M, Marino A, Anderson S, Swamydas M, et al. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice. Cardiovasc Res. 2015;106:478-87 pubmed publisher
  467. Lougaris V, Ravelli A, Villanacci V, Salemme M, Soresina A, Fuoti M, et al. Gastrointestinal Pathologic Abnormalities in Pediatric- and Adult-Onset Common Variable Immunodeficiency. Dig Dis Sci. 2015;60:2384-9 pubmed publisher
  468. Yukl S, Shergill A, Girling V, Li Q, Killian M, Epling L, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS ONE. 2015;10:e0121290 pubmed publisher
  469. McClintock S, Warner R, Ali S, Chekuri A, Dame M, Attili D, et al. Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine models. Cancer Biol Ther. 2015;16:724-32 pubmed publisher
  470. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed publisher
  471. Pone E, Lam T, Lou Z, Wang R, Chen Y, Liu D, et al. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses. J Immunol. 2015;194:3065-78 pubmed publisher
  472. Grabner B, Schramek D, Mueller K, Moll H, Svinka J, Hoffmann T, et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat Commun. 2015;6:6285 pubmed publisher
  473. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  474. Feuerstein R, Seidl M, Prinz M, Henneke P. MyD88 in macrophages is critical for abscess resolution in staphylococcal skin infection. J Immunol. 2015;194:2735-45 pubmed publisher
  475. Zhan R, Han Q, Zhang C, Tian Z, Zhang J. Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection. Infect Immun. 2015;83:1641-9 pubmed publisher
  476. Sell S, Dietz M, Schneider A, Holtappels R, Mach M, Winkler T. Control of murine cytomegalovirus infection by γδ T cells. PLoS Pathog. 2015;11:e1004481 pubmed publisher
  477. Buchwald Z, Yang C, Nellore S, Shashkova E, Davis J, Cline A, et al. A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells. J Bone Miner Res. 2015;30:1508-22 pubmed publisher
  478. Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, et al. Mucosal effects of tenofovir 1% gel. elife. 2015;4: pubmed publisher
  479. Crncec I, Pathria P, Svinka J, Eferl R. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors. Methods Mol Biol. 2015;1267:145-64 pubmed publisher
  480. Hu W, Dooley J, Chung S, Chandramohan D, Cimmino L, Mukherjee S, et al. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a. Blood. 2015;125:2206-16 pubmed publisher
  481. Shaw A, Pickup M, Chytil A, Aakre M, Owens P, Moses H, et al. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions. PLoS ONE. 2015;10:e0117908 pubmed publisher
  482. Hill E, Ng T, Burton B, Oakley C, Malik K, Wraith D. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol. 2015;45:1103-15 pubmed publisher
  483. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  484. Kanayama M, Inoue M, Danzaki K, Hammer G, He Y, Shinohara M. Autophagy enhances NFκB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity. Nat Commun. 2015;6:5779 pubmed publisher
  485. Das D, Feng Y, Mallis R, Li X, Keskin D, Hussey R, et al. Force-dependent transition in the T-cell receptor β-subunit allosterically regulates peptide discrimination and pMHC bond lifetime. Proc Natl Acad Sci U S A. 2015;112:1517-22 pubmed publisher
  486. Karsten C, Laumonnier Y, Eurich B, Ender F, Bröker K, Roy S, et al. Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse. J Immunol. 2015;194:1841-55 pubmed publisher
  487. Spada R, Rojas J, Pérez Yagüe S, Mulens V, Cannata Ortiz P, Bragado R, et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J Leukoc Biol. 2015;97:583-98 pubmed publisher
  488. Sullivan B, Teijaro J, de la Torre J, Oldstone M. Early virus-host interactions dictate the course of a persistent infection. PLoS Pathog. 2015;11:e1004588 pubmed publisher
  489. Djukic M, Sostmann N, Bertsch T, Mecke M, Nessler S, Manig A, et al. Vitamin D deficiency decreases survival of bacterial meningoencephalitis in mice. J Neuroinflammation. 2015;12:208 pubmed publisher
  490. Krysiak K, Tibbitts J, Shao J, Liu T, Ndonwi M, Walter M. Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells. Exp Hematol. 2015;43:319-30.e10 pubmed publisher
  491. Sakaguchi S, Hombauer M, Hassan H, Tanaka H, Yasmin N, Naoe Y, et al. A novel Cd8-cis-regulatory element preferentially directs expression in CD44hiCD62L+ CD8+ T cells and in CD8αα+ dendritic cells. J Leukoc Biol. 2015;97:635-44 pubmed publisher
  492. Bende R, Slot L, Hoogeboom R, Wormhoudt T, Adeoye A, Guikema J, et al. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheumatol. 2015;67:1074-83 pubmed publisher
  493. Ueno N, Lodoen M, Hickey G, Robey E, Coombes J. Toxoplasma gondii-infected natural killer cells display a hypermotility phenotype in vivo. Immunol Cell Biol. 2015;93:508-13 pubmed publisher
  494. Karamitros D, Patmanidi A, Kotantaki P, Potocnik A, Bähr Ivacevic T, Benes V, et al. Geminin deletion increases the number of fetal hematopoietic stem cells by affecting the expression of key transcription factors. Development. 2015;142:70-81 pubmed publisher
  495. Evrard M, Chong S, Devi S, Chew W, Lee B, Poidinger M, et al. Visualization of bone marrow monocyte mobilization using Cx3cr1gfp/+Flt3L-/- reporter mouse by multiphoton intravital microscopy. J Leukoc Biol. 2015;97:611-9 pubmed publisher
  496. Harmon E, Fronhofer V, Keller R, Feustel P, Zhu X, Xu H, et al. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques. J Am Heart Assoc. 2014;3:e001232 pubmed publisher
  497. Yin Y, Qin T, Wang X, Lin J, Yu Q, Yang Q. CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites. Mucosal Immunol. 2015;8:799-814 pubmed publisher
  498. Kim J, Li W, Choi Y, Lewin S, Verbeke C, Dranoff G, et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33:64-72 pubmed publisher
  499. Peroni A, Colato C, Schena D, Rongioletti F, Girolomoni G. Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol. 2015;72:131-9 pubmed publisher
  500. Svatek R, Zhao X, Morales E, Jha M, Tseng T, Hugen C, et al. Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial. Clin Cancer Res. 2015;21:303-11 pubmed publisher
  501. Kobold S, Steffen J, Chaloupka M, Grassmann S, Henkel J, Castoldi R, et al. Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer. J Natl Cancer Inst. 2015;107:364 pubmed publisher
  502. Fahl S, Harris B, Coffey F, Wiest D. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015;194:200-9 pubmed
  503. Baptista A, Roozendaal R, Reijmers R, Koning J, Unger W, Greuter M, et al. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. elife. 2014;3: pubmed publisher
  504. Schwartz C, Turqueti Neves A, Hartmann S, Yu P, Nimmerjahn F, Voehringer D. Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion. Proc Natl Acad Sci U S A. 2014;111:E5169-77 pubmed publisher
  505. Arndt B, Witkowski L, Ellwart J, Seissler J. CD8+ CD122+ PD-1- effector cells promote the development of diabetes in NOD mice. J Leukoc Biol. 2015;97:111-20 pubmed publisher
  506. Cui Z, Han D, Sun X, Zhang M, Feng X, Sun C, et al. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity. Appl Microbiol Biotechnol. 2015;99:667-80 pubmed publisher
  507. Backer R, Helbig C, Gentek R, Kent A, Laidlaw B, Dominguez C, et al. A central role for Notch in effector CD8(+) T cell differentiation. Nat Immunol. 2014;15:1143-51 pubmed publisher
  508. Morales D, Monte K, Sun L, Struckhoff J, Agapov E, Holtzman M, et al. Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice. J Virol. 2015;89:337-49 pubmed publisher
  509. Edwards C, Best S, Gun S, Claser C, James K, de Oca M, et al. Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection. Eur J Immunol. 2015;45:130-41 pubmed publisher
  510. Škrnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed publisher
  511. Novinger L, Ashikaga T, Krag D. Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer. Cancer Immunol Immunother. 2015;64:29-39 pubmed publisher
  512. Maneva Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213 pubmed publisher
  513. Ramnath N, van de Luijtgaarden K, van der Pluijm I, van Nimwegen M, van Heijningen P, Swagemakers S, et al. Extracellular matrix defects in aneurysmal Fibulin-4 mice predispose to lung emphysema. PLoS ONE. 2014;9:e106054 pubmed publisher
  514. Perino G, Ricciardi B, Jerabek S, Martignoni G, Wilner G, Maass D, et al. Implant based differences in adverse local tissue reaction in failed total hip arthroplasties: a morphological and immunohistochemical study. BMC Clin Pathol. 2014;14:39 pubmed publisher
  515. Naik E, Webster J, DeVoss J, Liu J, Suriben R, Dixit V. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947-55 pubmed publisher
  516. Dai M, Yip Y, Hellstrom I, Hellstrom K. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015;21:1127-38 pubmed publisher
  517. Al Barwani F, Young S, Baird M, Larsen D, Ward V. Mannosylation of virus-like particles enhances internalization by antigen presenting cells. PLoS ONE. 2014;9:e104523 pubmed publisher
  518. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  519. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  520. Flach J, Bakker S, Mohrin M, Conroy P, Pietras E, Reynaud D, et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature. 2014;512:198-202 pubmed publisher
  521. Johannesson B, Sattler S, Semenova E, Pastore S, Kennedy Lydon T, Sampson R, et al. Insulin-like growth factor-1 induces regulatory T cell-mediated suppression of allergic contact dermatitis in mice. Dis Model Mech. 2014;7:977-85 pubmed publisher
  522. Chung Y, Kim E, Abdel Wahab O. Femoral bone marrow aspiration in live mice. J Vis Exp. 2014;: pubmed publisher
  523. Larsen J, Dall M, Antvorskov J, Weile C, Engkilde K, Josefsen K, et al. Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion. Eur J Immunol. 2014;44:3056-67 pubmed publisher
  524. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  525. Knoop K, McDonald K, McCrate S, McDole J, Newberry R. Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon. Mucosal Immunol. 2015;8:198-210 pubmed publisher
  526. Honjo K, Kubagawa Y, Suzuki Y, Takagi M, Ohno H, Bucy R, et al. Enhanced auto-antibody production and Mott cell formation in Fc?R-deficient autoimmune mice. Int Immunol. 2014;26:659-72 pubmed publisher
  527. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  528. Cowan J, McCarthy N, Parnell S, White A, Bacon A, Serge A, et al. Differential requirement for CCR4 and CCR7 during the development of innate and adaptive ??T cells in the adult thymus. J Immunol. 2014;193:1204-12 pubmed publisher
  529. Vogelzang A, Perdomo C, Zedler U, Kuhlmann S, Hurwitz R, Gengenbacher M, et al. Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ?ureC::hly vaccine's superior protection against tuberculosis. J Infect Dis. 2014;210:1928-37 pubmed publisher
  530. Zhou Q, Ho A, Schlitzer A, Tang Y, Wong K, Wong F, et al. GM-CSF-licensed CD11b+ lung dendritic cells orchestrate Th2 immunity to Blomia tropicalis. J Immunol. 2014;193:496-509 pubmed publisher
  531. Mise Omata S, Alles N, Fukazawa T, Aoki K, Ohya K, Jimi E, et al. NF-?B RELA-deficient bone marrow macrophages fail to support bone formation and to maintain the hematopoietic niche after lethal irradiation and stem cell transplantation. Int Immunol. 2014;26:607-18 pubmed publisher
  532. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676-86 pubmed publisher
  533. Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, Deretzi G, et al. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry. 2014;85:1386-95 pubmed publisher
  534. Jakobsson T, Vedin L, Hassan T, Venteclef N, Greco D, D AMATO M, et al. The oxysterol receptor LXR? protects against DSS- and TNBS-induced colitis in mice. Mucosal Immunol. 2014;7:1416-28 pubmed publisher
  535. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  536. Rocca C, Ur S, Harrison F, Cherqui S. rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery: conclusion of a comparative study. Gene Ther. 2014;21:618-28 pubmed publisher
  537. Qian L, Zhang M, Wu S, Zhong Y, Van Tol E, Cai W. Alkylglycerols modulate the proliferation and differentiation of non-specific agonist and specific antigen-stimulated splenic lymphocytes. PLoS ONE. 2014;9:e96207 pubmed publisher
  538. Dupont C, Christian D, Selleck E, Pepper M, Leney Greene M, Harms Pritchard G, et al. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 2014;10:e1004047 pubmed publisher
  539. Könnecke I, Serra A, El Khassawna T, Schlundt C, Schell H, Hauser A, et al. T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion. Bone. 2014;64:155-65 pubmed publisher
  540. Koga T, Hedrich C, Mizui M, Yoshida N, Otomo K, Lieberman L, et al. CaMK4-dependent activation of AKT/mTOR and CREM-? underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124:2234-45 pubmed publisher
  541. Vanoaica L, Richman L, Jaworski M, Darshan D, Luther S, Kühn L. Conditional deletion of ferritin h in mice reduces B and T lymphocyte populations. PLoS ONE. 2014;9:e89270 pubmed publisher
  542. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  543. Rizzo S, Basso C, Troost D, Aronica E, Frigo A, Driessen A, et al. T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2014;7:224-9 pubmed publisher
  544. Wang B, Dai S, Dong Z, Sun Y, Song X, Guo C, et al. The modulation of endoplasmic reticulum stress by chemical chaperone upregulates immune negative cytokine IL-35 in apolipoprotein E-deficient mice. PLoS ONE. 2014;9:e87787 pubmed publisher
  545. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  546. Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, et al. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor beta signaling. J Crohns Colitis. 2014;8:770-4 pubmed publisher
  547. Bashour K, Gondarenko A, Chen H, Shen K, Liu X, Huse M, et al. CD28 and CD3 have complementary roles in T-cell traction forces. Proc Natl Acad Sci U S A. 2014;111:2241-6 pubmed publisher
  548. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed publisher
  549. Yang C, Li J, Chiu L, Lan J, Chen D, Chuang H, et al. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J Immunol. 2014;192:1547-57 pubmed publisher
  550. Hu Y, Xiao H, Shi T, Oppenheim J, Chen X. Progranulin promotes tumour necrosis factor-induced proliferation of suppressive mouse CD4? Foxp3? regulatory T cells. Immunology. 2014;142:193-201 pubmed publisher
  551. Walker C, Hautefort I, Dalton J, Overweg K, Egan C, Bongaerts R, et al. Intestinal intraepithelial lymphocyte-enterocyte crosstalk regulates production of bactericidal angiogenin 4 by Paneth cells upon microbial challenge. PLoS ONE. 2013;8:e84553 pubmed publisher
  552. McGuire D, Rowse A, Li H, Peng B, Sestero C, Cashman K, et al. CD5 enhances Th17-cell differentiation by regulating IFN-? response and ROR?t localization. Eur J Immunol. 2014;44:1137-42 pubmed publisher
  553. Murphy K, Erickson J, Johnson C, Seiler C, Bedi J, Hu P, et al. CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma. J Immunol. 2014;192:224-33 pubmed publisher
  554. Griffiths K, Stylianou E, Poyntz H, Betts G, Fletcher H, McShane H. Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice. PLoS ONE. 2013;8:e78312 pubmed publisher
  555. Luan G, Gao Q, Guan Y, Zhai F, Zhou J, Liu C, et al. Upregulation of adenosine kinase in Rasmussen encephalitis. J Neuropathol Exp Neurol. 2013;72:1000-8 pubmed publisher
  556. Nussbaum J, Van Dyken S, von Moltke J, Cheng L, Mohapatra A, Molofsky A, et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature. 2013;502:245-8 pubmed publisher
  557. Povinelli B, Nemeth M. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells. 2014;32:105-15 pubmed publisher
  558. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed publisher
  559. Pioli P, Dahlem T, Weis J, Weis J. Deletion of Snai2 and Snai3 results in impaired physical development compounded by lymphocyte deficiency. PLoS ONE. 2013;8:e69216 pubmed publisher
  560. Rommel P, Bosque D, Gitlin A, Croft G, Heintz N, Casellas R, et al. Fate mapping for activation-induced cytidine deaminase (AID) marks non-lymphoid cells during mouse development. PLoS ONE. 2013;8:e69208 pubmed publisher
  561. Gautron L, Rutkowski J, Burton M, Wei W, Wan Y, Elmquist J. Neuronal and nonneuronal cholinergic structures in the mouse gastrointestinal tract and spleen. J Comp Neurol. 2013;521:3741-67 pubmed publisher
  562. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492-6 pubmed publisher
  563. Fischer M, Wimmer I, Hoftberger R, Gerlach S, Haider L, Zrzavy T, et al. Disease-specific molecular events in cortical multiple sclerosis lesions. Brain. 2013;136:1799-815 pubmed publisher
  564. Nichele I, Zamo A, Bertolaso A, Bifari F, Tinelli M, Franchini M, et al. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type. PLoS ONE. 2012;7:e52811 pubmed publisher
  565. Kłossowicz M, Scirka B, Suchanek J, Marek Bukowiec K, Kisielow P, Aguado E, et al. Assessment of caspase mediated degradation of linker for activation of T cells (LAT) at a single cell level. J Immunol Methods. 2013;389:9-17 pubmed publisher
  566. Irla M, Guenot J, Sealy G, Reith W, Imhof B, Serge A. Three-dimensional visualization of the mouse thymus organization in health and immunodeficiency. J Immunol. 2013;190:586-96 pubmed publisher
  567. Yassai M, Cooley B, Gorski J. Developmental dynamics of post-selection thymic DN iNKT. PLoS ONE. 2012;7:e43509 pubmed publisher
  568. O CONNOR T, Frei N, Sponarova J, Schwarz P, Heikenwalder M, Aguzzi A. Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes. PLoS Pathog. 2012;8:e1002867 pubmed publisher
  569. Daigneault M, de Silva T, Bewley M, Preston J, Marriott H, Mitchell A, et al. Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection. PLoS Pathog. 2012;8:e1002814 pubmed publisher
  570. Golias J, Schwarzer M, Wallner M, Kverka M, Kozakova H, Srůtková D, et al. Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy. PLoS ONE. 2012;7:e37156 pubmed publisher
  571. Jenkins C, Shevchuk O, Giambra V, Lam S, Carboni J, Gottardis M, et al. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein. Exp Hematol. 2012;40:715-723.e6 pubmed publisher
  572. Chevrier S, Genton C, Malissen B, Malissen M, Acha Orbea H. Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Front Immunol. 2012;3:27 pubmed publisher
  573. Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney N, Schuijs M, et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS ONE. 2012;7:e32371 pubmed publisher
  574. Zeng M, Southern P, Reilly C, Beilman G, Chipman J, Schacker T, et al. Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy. PLoS Pathog. 2012;8:e1002437 pubmed publisher
  575. Schneckenleithner C, Bago Horvath Z, Dolznig H, Neugebauer N, Kollmann K, Kolbe T, et al. Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias. Oncotarget. 2011;2:1043-54 pubmed
  576. West N, Milne K, Truong P, MacPherson N, Nelson B, Watson P. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res. 2011;13:R126 pubmed publisher
  577. Badeaux A, Yang Y, Cardenas K, Vemulapalli V, Chen K, Kusewitt D, et al. Loss of the methyl lysine effector protein PHF20 impacts the expression of genes regulated by the lysine acetyltransferase MOF. J Biol Chem. 2012;287:429-37 pubmed publisher
  578. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed publisher
  579. Galand C, Donnou S, Crozet L, Brunet S, Touitou V, Ouakrim H, et al. Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma. PLoS ONE. 2011;6:e24622 pubmed publisher
  580. Ripich T, Jessberger R. SWAP-70 regulates erythropoiesis by controlling ?4 integrin. Haematologica. 2011;96:1743-52 pubmed publisher
  581. Ota N, Wong K, Valdez P, Zheng Y, Crellin N, Diehl L, et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol. 2011;12:941-8 pubmed publisher
  582. Lorenzi L, Lonardi S, Petrilli G, Tanda F, Bella M, Laurino L, et al. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders. Hum Pathol. 2012;43:209-15 pubmed publisher
  583. Deswal S, Schulze A, Hofer T, Schamel W. Quantitative analysis of protein phosphorylations and interactions by multi-colour IP-FCM as an input for kinetic modelling of signalling networks. PLoS ONE. 2011;6:e22928 pubmed publisher
  584. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  585. Hemmers S, Teijaro J, Arandjelovic S, Mowen K. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE. 2011;6:e22043 pubmed publisher
  586. West N, Panet Raymond V, Truong P, Alexander C, Babinszky S, Milne K, et al. Intratumoral Immune Responses Can Distinguish New Primary and True Recurrence Types of Ipsilateral Breast Tumor Recurrences (IBTR). Breast Cancer (Auckl). 2011;5:105-15 pubmed publisher
  587. Yan S, Wang L, Liu N, Wang Y, Chu Y. Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol Cell Biol. 2012;90:421-8 pubmed publisher
  588. Tousif S, Singh Y, Prasad D, Sharma P, Van Kaer L, Das G. T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. PLoS ONE. 2011;6:e19864 pubmed publisher
  589. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  590. Reuwer A, van Eijk M, Houttuijn Bloemendaal F, van der Loos C, Claessen N, Teeling P, et al. The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis?. J Endocrinol. 2011;208:107-17 pubmed publisher
  591. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  592. Zavitz C, Bauer C, Gaschler G, Fraser K, Strieter R, Hogaboam C, et al. Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza. J Immunol. 2010;184:2001-13 pubmed publisher
  593. Zou Y, Chen T, Han M, Wang H, Yan W, Song G, et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;184:466-75 pubmed publisher
  594. MANICONE A, Huizar I, McGuire J. Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin). Am J Pathol. 2009;175:2319-31 pubmed publisher
  595. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  596. Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G. Myeloid cells contribute to tumor lymphangiogenesis. PLoS ONE. 2009;4:e7067 pubmed publisher
  597. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  598. Milne K, Barnes R, Girardin A, Mawer M, Nesslinger N, Ng A, et al. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS ONE. 2008;3:e3409 pubmed publisher
  599. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, et al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008;18:846-57 pubmed publisher
  600. Gwack Y, Srikanth S, Oh Hora M, Hogan P, Lamperti E, Yamashita M, et al. Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol. 2008;28:5209-22 pubmed publisher
  601. Jeannet G, Scheller M, Scarpellino L, Duboux S, Gardiol N, Back J, et al. Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood. 2008;111:142-9 pubmed
  602. Jiang L, Yang P, He H, Li B, Lin X, Hou S, et al. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation. Mol Vis. 2007;13:968-74 pubmed
  603. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  604. Sevigny C, Li L, Awad A, Huang L, McDuffie M, Linden J, et al. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol. 2007;178:4240-9 pubmed
  605. Xin K, Mizukami H, Urabe M, Toda Y, Shinoda K, Yoshida A, et al. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells. J Virol. 2006;80:11899-910 pubmed
  606. Day Y, Huang L, Ye H, Li L, Linden J, Okusa M. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol. 2006;176:3108-14 pubmed
  607. Geng H, Zhang G, Xiao H, Yuan Y, Li D, Zhang H, et al. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma. Int J Cancer. 2006;118:2657-64 pubmed
  608. Gupta R, Karpatkin S, Basch R. Hematopoiesis and stem cell renewal in long-term bone marrow cultures containing catalase. Blood. 2006;107:1837-46 pubmed
  609. Krieg C, Han P, Stone R, Goularte O, Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175:6420-7 pubmed
  610. Takeuchi A, Usui Y, Takeuchi M, Hattori T, Kezuka T, Suzuki J, et al. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response. Invest Ophthalmol Vis Sci. 2005;46:3753-60 pubmed
  611. Irwin S, Izzo A, Dow S, Skeiky Y, Reed S, Alderson M, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun. 2005;73:5809-16 pubmed
  612. Nakae S, Suto H, Kakurai M, Sedgwick J, Tsai M, Galli S. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci U S A. 2005;102:6467-72 pubmed
  613. Futagawa T, Akiba H, Kodama T, Takeda K, Hosoda Y, Yagita H, et al. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int Immunol. 2002;14:275-86 pubmed
  614. Lepault F, Gagnerault M, Faveeuw C, Bazin H, Boitard C. Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur J Immunol. 1995;25:1502-7 pubmed
  615. Havran W, Poenie M, Kimura J, Tsien R, Weiss A, Allison J. Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes. Nature. 1987;330:170-3 pubmed
  616. Leo O, Foo M, Sachs D, Samelson L, Bluestone J. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A. 1987;84:1374-8 pubmed
  617. Samelson L, O Shea J, Luong H, Ross P, Urdahl K, Klausner R, et al. T cell antigen receptor phosphorylation induced by an anti-receptor antibody. J Immunol. 1987;139:2708-14 pubmed
  618. Harding F, McArthur J, Gross J, Raulet D, Allison J. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature. 1992;356:607-9 pubmed